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The Bovine Salivary Protein 30b (BSP30b) is a member of the palate, lung, and 
nasal epithelium clone (PLUNC) family which includes human 
bactericidal/permeability-increasing protein (BPI) and lipopolysaccaride binding 
protein (LBP). BSP30b is predominantly found in bovine saliva but its function is 
not understood. Although PLUNC family members are proposed to be lipid binding 
proteins, in most cases their lipid ligands are also unknown. 
Here, the X-ray crystal structure of BSP30b is solved at 2 Å resolution using a 
double methionine mutant and Se-Met MAD phasing. Each molecule adopts a 
slightly curved cylindrical structure with a hydrophobic channel formed by an α/β 
wrap, which is highly conserved in the PLUNC family. The structure of BSP30b 
complexed with oleic acid is also presented where the ligand is accommodated 
within the hydrophobic channel. The electron density for oleic acid suggests that 
the ligand is only partially occupied in the binding site implying that oleic acid 
might not be the preferred ligand of BSP30b.  
Nonetheless, GFP-tagged BSP30b binds to the surface of olive oil droplets, as 
observed by fluorescent microscopy. Bacteria extracted directly from rumen 
samples indicate that the GFP_BSP30b fusion protein binds to a small number of 
selected bacterial strains in vivo. These results suggest that BSP30b could have a 
specific range of lipid ligands and may play important roles via its interaction with 
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Chapter One. Introduction 
1.1 Ruminant salivary glands and saliva composition 
In mammals, saliva serves as a lubricant in the oral cavity, assisting mastication and 
deglutition (McDougall, 1948). However, in ruminants, saliva has more extensive 
roles. Firstly, their saliva forms a fluid medium which transports the “chewing cud” 
back to the mouth for rumination and carries the ingesta onwards through the 
stomachs to the small intestine. Secondly, their saliva also forms a buffered medium 
(bicarbonate phosphate) for the survival and growth of ruminal micro-organisms 
(McDougall, 1948). 
1.1.1 Salivary glands in ruminants 
Ruminant salivary glands can be categorised into two types – major and minor 
glands (Fig. 1.1). The minor glands are distributed in the oral cavity mucosa or 
submucosa and they are named according to their location: buccal, labial, palatine 
and lingual (Elewa, Ichii, Otsuka, Hashimoto, & Kon, 2014). 
In ruminants, the major salivary glands consist of parotid, mandibular and 
sublingual glands (Dyce, 1996). The parotid glands are the major and largest 
salivary gland in the ruminant. Both parotid glands are located ventral to the ear 
and its secreted saliva will drain into the mouth through a single large duct (parotid 
duct), which has a final opening in the caudal aspect of the mouth at the level of the 
second to last cheek tooth (Dyce, 1996; Tadjalli, Dehghani, & Ghadiri, 2002). The 
left and right submandibular glands are more axial than the parotid glands，located 
at the back of the jaw on the floor of the oral cavity. Each submandibular gland has 




sublingual caruncle (Dyce, 1996; Tadjalli et al., 2002). Each sublingual salivary 
gland contains two parts: monostomatic and polystomatic parts. The left or right 
monostomatic gland is located in front of its respective polystomatic gland and both 
monostomatic glands secret saliva into the mouth through a single duct. The 
polystomatic glands lie on either side of the tongue and drain saliva on the floor of 
the mouth (Dyce, 1996). 
 
 
Figure 1.1 Schematic diagram of salivary glands in cattle. Used with permission from (Dyce, 1996). 
 
The major salivary glands consist of three types of cells: acinar, duct and 
myoepithelial cells. The acinar cells make up the largest part of the salivary glands 
and they are further classified into two types: serous cells and mucous cells. Serous 
cells are large granular cells with round nuclei that secrete a watery fluid. In contrast, 
mucous cells have a clear cytoplasm and flattened nucleus and secrete a mucus-rich 
saliva, which is high in carbohydrates and proteins (Kay, 1966). The parotid glands 




serous acini (Elewa et al., 2010). The saliva secreted from sublingual glands is 
mucus-rich and hypotonic as they are mostly composed of mucous acini. The 
submandibular gland is made up of a mixture of serous and mucous cells and hence 
its secreted saliva is variably mucus and hypotonic (Kay, 1966). 
1.1.2 Ruminant saliva 
Ruminant saliva is an isotonic, bicarbonate phosphate buffer with high pH, which 
helps to maintain the acid-base equilibrium of the ruminal contents by neutralizing 
acids formed by fermentation in the rumen (Singh & Singh, 2017). Compared with 
other mammals, ruminants can produce large amounts of saliva daily due to the 
large salivary glands. It is estimated that 100-190 litres of saliva can be produced 
by a single adult cattle daily. 
Due to the different compositions of cells within each major salivary gland, 
different responses can be accomplished dependent upon the presence or absence 
of stimulation. The sublingual and submandibular glands, when stimulated by 
feeding, secrete a saliva which is hypotonic and weakly buffered. It functions as a 
lubricant to the bolus of food (McDougall, 1948). In contrast, the parotid saliva is 
released in large amounts during eating and rumination and its secretion continues 
at a reduced rate during the intervals of rest. It has a high alkalinity and buffering 
power and hence is crucial for the maintenance of normal rumen function (Kay, 
1966; McDougall, 1948). 
1.1.3 Ruminant saliva proteins and their functions 
Although saliva is predominantly a watery fluid, it also contains a complex mixture 




from the blood (Pedersen, Bardow, Jensen, & Nauntofte, 2002). The growing 
interest in health issues and productivity of ruminants has stimulated studies on 
their salivary proteins, especially with advances in proteomic techniques (Lamy & 
Mau, 2012; Shibata et al., 2009). 
Recently, an in-depth systematic proteomic analysis of saliva from different 
mammal species, including cattle, was carried out using GeLC-MS/MS (SDS-
PAGE-LC coupled to MS/MS) methods (de Sousa-Pereira et al., 2015). According 
to their analysis, 74 proteins were identified in cattle’s saliva, of which nine proteins 
were higher than 0.9 % in abundance, namely CA6 (carbonic anhydrase 6), 
CSN1S1 (casein 1S1), CSTB (cystatin B or stefin B), HBB (haemoglobin subunit 
beta), KRT1 (keratin 1), LPO (lactoperoxidase), Obp1f (odorant binding protein 1f), 
PIP (prolactin-inducible protein), and SPLUNC2a (BSP30a). 
Carbonic anhydrases are a group of zinc metalloenzymes which are responsible for 
the interconversion of carbon dioxide to bicarbonate (Tashian, 1989). They are 
known to be involved in the maintenance of the buffer capacity of saliva. Of which, 
CA6 is a 42 kDa secreted protein which has the ability to bind to the enamel surface 
and maintain pH homeostasis (Gilmour, 2010; Kivela, Parkkila, Parkkila, Leinonen, 
& Rajaniemi, 1999). 
Casein is the name for a group of secretory calcium-binding phosphoproteins. It has 
been reported that casein acts in calcium homeostasis in saliva and appears to 
prevent adherence of salivary components and bacteria to enamel, which protects 
the hard oral tissues (Johansson & Lif Holgerson, 2011; Rijnkels, Elnitski, Miller, 




CSTB (cystatin B or stefin B) is a cystatin family 1 protein of the cystatin 
superfamily. It was initially found to be an intracellular and reversible inhibitor of 
papain-like cysteine proteinases, which has a unique free Cys in the N-terminal 
segment of the proteinase binding region (Pol & Bjork, 2001; Turk, Turk, & Turk, 
1997). It has been proposed to have a general protective role in mammals and most 
likely prevents inappropriate proteolysis caused by the action of lysosomal cysteine 
proteinases (Turk, Turk, & Turk, 2000; Turk et al., 1997). More recently, its 
presence in saliva as S-modified derivatives was detected, but its function is still 
unclear (Cabras et al., 2012). 
Haemoglobin is a highly conserved oxygen transport protein found in mammalian 
red blood cells, its presence in saliva is linked to a range of diseases, particularly 
periodontitis (Maeng et al., 2016; Marti, Friedman, Cabrini, & Costa, 2002).  
Similar to haemoglobin, the increased concentration of keratin in saliva is also 
linked to gingivitis and periodontitis (McLaughlin, Kirkham, Kowolik, & Robinson, 
1996). 
Lactoperoxidase is a heme containing protein which is released into several body 
fluids including the saliva. Within saliva, it is secreted by acinus cells of the salivary 
gland and helps to maintain the oral bacterial homeostasis by catalysing the 
oxidation of thiocyanate (SCN−) to hypo-thiocyanite (−OSCN) (Chandler & Day, 
2012; Ihalin, Loimaranta, & Tenovuo, 2006). 
Odorant binding proteins are mainly found in the nasal mucus of vertebrates and in 
the sensillar lymph of insects. They act as olfactory perception because of their high 
affinity to odors and pheromones, but their function in saliva has not been clearly 




Prolactin-inducible protein in saliva is considered to have an important role in host 
defence by promoting aggregation of oral bacteria (Nistor, Bowden, Blanchard, & 
Myal, 2009).  
SPLUNC2a (BSP30a) belongs to PLUNC family of proteins and the structure and 
function of this family of bovine salivary proteins is the subject of this thesis 
(Section 1.2.2). 
 
1.2 PLUNC (palate, lung, and nasal epithelium clone) 
proteins 
PLUNC proteins are a family of proteins which are predominantly expressed in the 
upper respiratory tract, nasal mucosa, and oral cavity. The first gene belonging to 
this group was identified in the developing palate of the mouse embryo (Weston et 
al., 1999). It was noticed that its RNA was expressed strongly in the mouse embryo 
on day 14 after gestation at discrete regions of the nasal epithelium. In addition, 
significant expression in the adult mouse was seen in the tracheal and bronchial 
epithelium (Weston et al., 1999). 
The sequence of murine plunc contains an ORF (open reading frame) of 834 bp 
(base pairs), giving a putative protein product of molecular mass 28,618 Da. 
Analysis of the predicted amino acid sequence indicates that it is a secreted protein 
which has homology with two salivary gland proteins: the von Ebner minor salivary 





Systematic study of this gene revealed that it is located in a gene cluster on 
chromosome 2 (Fig. 1.2) together with seven other plunc genes and two genes 
coding for parotid secretory protein (PSP) and von Ebner minor salivary gland 
protein (VEMSGP), respectively (LeClair, 2003). This cluster is also known as BPI 
(bactericidal/permeability-increasing protein) fold containing family (BPIF) gene 
locus because the protein structures of those genes in this locus share high sequence 
similarity with BPI, which is an important host defence molecule in mammals and 
has potent antimicrobial activity against Gram negative bacteria through its binding 
to lipopolysaccharide (LPS) (Haigh et al., 2008; LeClair, 2003). 
1.2.1 Human PLUNC family 
The human PLUNC gene locus, located on chromosome 20, spans a region of 
approximately 300 kb and contains nine plunc genes, and two pseudogenes (Fig. 
1.2) (Haigh et al., 2008). Among those genes, splunc1 (also known as BPIFA1) has 
attracted more attention and its protein has been intensively studied because of its 
continuous secretion in the airways, which may have multiple functions in 
combating respiratory infection induced by Gram-negative bacteria (Garland et al., 
2013).  
The antimicrobial activity of SPLUNC1 was first reported in nasopharyngeal 
carcinoma (NPC) epithelial HNE1 cells (Zhou et al., 2006). Co-localization of 
GFP-tagged SPLUNC1 with Gram-negative nanobacteria (NB) within NPC 
epithelial HNE1 cells indicated the potential binding between SPLUNC1 and the 
LPS of NB, which can play an important role in the host defence of nasopharyngeal 
epithelium (Zhou et al., 2006). Further studies have shown its growth inhibition to 




(McGillivary & Bakaletz, 2010; Zhou et al., 2008). Moreover, SPLUNC1 may act 
as a novel airway surfactant with antibiofilm activity which disrupts the biofilm 
formation and growth of P. aeruginosa in airways (J. Bartlett et al., 2011; Gakhar 
et al., 2010a). Based on the sequence similarity between SPLUNC1 and BPI, it was 
predicted that SPLUNC1 could also bind to LPS in a similar way to BPI. Indeed, 
several studies have reported direct binding of SPLUNC1 to LPS (Di, 2011; 
Ghafouri, Kihlstrom, Tagesson, & Lindahl, 2004; Sayeed, Nistico, St Croix, & Di, 
2013a; Zhou et al., 2008). However, failure to bind has also reported elsewhere 
(Campos et al., 2004; Ning et al., 2014).  
More recently, SPLUNC1 is proposed to be a pH-sensitive regulator of epithelial 
Na+ channel (ENaC), which in normal airways can preserve the ASL (airway 
surface liquid) volume through its inhibition of the epithelial Na+ channel (ENaC)-
dependent Na+ absorption (Garland et al., 2013). However, in the acidic cystic 
fibrosis (CF) airway environment it is unable to inhibit ENaC which leads to the 
airways surface liquid (ASL) dehydration, a major syndrome of CF. SPLUNC1 
regains its ability to prevent CF ASL hyperabsorption following alkalinisation of 
CF airway cultures. Structural studies reveal that its pH-sensitive regulation comes 
from two pH-sensitive salt bridges in the structure. Removal of these two salt 
bridges will render SPLUNC1 pH-insensitive and unable to regulate ASL volume 





Figure 1.2 The PLUNC protein family in cattle, human and mouse. The direction of the ORF is indicated by 
the arrowed end of each gene. Used with permission from (Haigh et al., 2008). 
 
1.2.2 Bovine PLUNC family 
Cattle have an expanded PLUNC gene locus, which contains thirteen plunc genes 
and one pseudogene on chromosome 13 (Fig. 1.2) (Wheeler et al., 2007). Nine of 
the thirteen plunc genes are orthologous to genes in the human and mouse locus, 
and are thought to have similar roles in host defence. The remaining four genes, 
namely BSP30a, BSP30b, BSP30c, and BSP30d, have arisen in cattle through a 
series of duplications which may be a characteristic of ruminants and suggests that 
their proteins may contribute to the functions of ruminant physiology (Wheeler et 
al., 2007). 
The first described PLUNC protein in cattle was named “BSP30”, and had a mass 




(Rajan, Morris, Carruthers, Wilkins, & Wheeler, 1996). This “BSP30” protein is 
one of the most abundant proteins in bovine saliva, with a concentration of 0.1-0.5 
mg/ml. Its abundance was proposed to be associated with the susceptibility of the 
cattle to pasture bloat, a metabolic disease characterized by build-up of stable foam 
in the rumen and hence impairment of the eructation mechanism, causing rumen 
distension and respiratory distress (Clarke & Reid, 1974). Further investigation of 
this protein revealed that it is a mixture of two closely related proteins - BSP30a 
and BSP30b, sharing 83% amino acid identity, with expression restricted to salivary 
tissue (Wheeler et al., 2002). A gene expression study indicated that the mRNAs of 
the four BSP30 genes are most abundant in tissues associated with the oral cavity 
and airways. Notably, BSP30a and BSP30b are abundantly expressed in the salivary 
gland independently of one another and their proteins are secreted into saliva, 
accounting for 15-30% of the total protein in bovine saliva (Wheeler, Hood, Oden, 
McCracken, & Morris, 2003). 
 
Figure 1.3 Immunohistochemical analysis of BSP30 proteins in bovine salivary tissues. Antibody raised in 
rabbit recognizes both BSP30a and BSP30b. The immunoreactive signal (dark areas, and examples arrowed) 
was visualized with diaminobenzidine at x20 and x200 magnification. Used with permission from (Wheeler, 





Immunohistochemical analysis of bovine salivary glands with antibodies specific 
for both BSP30a and BSP30b suggested that they are localized to the serous 
secretory cells (Fig. 1.3) (Wheeler et al., 2011). Further analysis with Western blot 
revealed that BSP30b is present in the parotid, submandibular and buccal salivary 
glands; whilst BSP30a is only present in the submandibular gland, although its 
mRNA was shown to be expressed abundantly in the parotid (Fig. 1.4) (Haigh et 
al., 2008; Wheeler et al., 2003). Functional studies suggest that both BSP30a and 
BSP30b can suppress the growth of Pseudomonas aeruginosa with moderate 
potency but suppression was not observed for other pathogens tested, indicating 
that (unlike BPI proteins) the BSP30 proteins may not have a primary function as 
bactericidal proteins (Haigh et al., 2008; Wheeler et al., 2011). It has also been 
observed that both BSP30a and BSP30b have no significant LPS binding activity, 
suggesting that the mechanism of their antibacterial activity is independent of LPS 
opsonisation (Haigh et al., 2008). 
 
Figure 1.4 Western analysis of BSP30a and BSP30b expression in the major bovine salivary glands. Used with 
permission from (Haigh et al., 2008) 
 
1.3 TULIP (tubular lipid-binding) superfamily 
The TULIP superfamily consists of three protein families – SMP-like, BPI-like, and 




superfamily all have the N-terminal domain of BPI, also known as a TULIP domain. 
The tertiary structure of this domain has a long bent helix wrapped in a highly 
curved anti-parallel β-sheet, forming a hydrophobic channel in the central part of 
the protein (Alva & Lupas, 2016).  
Despite the structural conservation among proteins within this superfamily, their 
amino acid sequences are not well conserved. The Hidden Markov Model (HMM) 
analysis (Schuster-Bockler, Schultz, & Rahmann, 2004) of the LBP_BPI_CETP 
family indicates limited amino acid sequence conservation in the alignment (Fig. 
1.5). The HMM logo reveals a low level of conservation involving just a few 
hydrophobic amino acids such as leucine at positions 2, 149, and 161, isoleucine at 
position 46. Only the two cystines at positions 115 and 154 are highly conserved 
across this family. These two cystines form a disulphide bond, which is proposed 






Figure 1.5 Hidden Markov Model (HMM) logo of the LBP_BPI_CETP family 
shows the distribution of amino acids from a multiple alignment 
(https://pfam.xfam.org/family/PF01273#tabview=tab3). The height and width of 
each letter at each position is proportional to its occurrence and relative role, 
respectively. The red bars represent regions of residue insertion in the alignment. 
Amino acid colours reflect their biological properties (red = charged; blues = 
polar, uncharged; yellows = aliphatic; greens = aromatic). 
1.3.1 BPI-like Protein Family 
The BPI-like family includes BPI (the bactericidal/permeability-increasing protein), 
LBP (LPS-binding protein), CETP (the cholesteryl ester transfer protein), PLTP 
(the phospholipid transfer protein), and PLUNC (Alva & Lupas, 2016). They are 
either involved in innate immunity against bacteria through their ability to bind LPS, 




BPI is a predominantly intracellular protein found in the primary granules of 
polymorphonuclear neutrophils (Elsbach & Weiss, 1995). BPI binds to LPS with 
high affinity and it has potent bactericidal activity against Gram-negative bacteria 
in the phagocytic compartment of the neutrophil to kill engulfed bacteria (Weiss, 
Elsbach, Olsson, & Odeberg, 1978). The three dimensional structure of BPI is 
initially solved at 2.4 Å (Beamer, Carroll, & Eisenberg, 1999) and later solved at 
1.7 Å (Kleiger, Beamer, Grothe, Mallick, & Eisenberg, 2000). Unlike other soluble 
proteins, BPI has an interesting “boomerang” shape (Fig. 1.6). Its N-terminal 
domain and C-terminal domain are connected by a proline-rich linker. Although the 
sequence similarity between the N- and C-terminal domains is very low (<20%), 
they both have a tubular shape formed by two α helices and a highly twisted 
antiparallel β sheet. Electrospray mass spectrometry confirmed that each tubular 
cavity has a phosphatidylcholine sitting in it. Based on the similarities between LPS 
and phosphatidylcholine, further research showed that BPI binds to the lipid A 
region of LPS with high affinity. Combined with antibacterial studies, it was 
suggested that BPI has bactericidal activity against Gram negative bacteria via LPS 
binding (Beamer et al., 1999). 
 
Figure 1.6 Cartoon representation of human BPI. Its N-terminal domain is blue and C-terminal domain is red. 





Another protein belonging to this family is LBP, which is constitutively produced 
by hepatocytes and secreted into the bloodstream (Tobias, Soldau, & Ulevitch, 
1986). It also binds to LPS with high affinity, and plays a critical role in the 
activation of immune cells by LPS (Hailman et al., 1994; Tobias, Soldau, Gegner, 
Mintz, & Ulevitch, 1995). After binding LPS, LBP delivers it to a cell surface 
protein (CD14) of macrophages and monocytes, activating the inflammatory 
cascade (Fig. 1.7a). Interestingly, in vitro studies show that, in contrast to LBP, BPI 
can neutralize the inflammatory properties of LPS (von der Mohlen et al., 1995). 
This observation suggested that the inflammatory response of LBP to LPS in the 
blood stream could be alleviated by addition of BPI to the bloodstream. The three 
dimensional structure of LPS (Fig. 1.7b) is similar to BPI, which also has a 
boomerang-like structure (Eckert et al., 2013). Unlike BPI, only the N-terminal 
domain of LBP binds LPS; whereas its C-terminal domain is believed to mediate 





Figure 1.7 Structure of LBP and its effects on the LPS induced inflammatory cascade. 3a, schematic illustration 
of the different effects of LBP and BPI on the LPS induced inflammatory cascade. 3b, Cartoon representation 
of the crystal structure of LBP. Its N-terminal domain is in blue and C-terminal domain is in green. Used with 
permission from (Beamer et al., 1999; Eckert et al., 2013). 
 
CETP is a hydrophobic glycoprotein, mediating the transfer of neutral lipids, 
including cholesteryl esters and triglycerides, between high-density lipoproteins 
(HDL), low-density lipoproteins (LDL) and very-low-density lipoproteins (VLDL) 
(Barter et al., 2003; Tall, 1993). The structure of CETP at 2.2 Å resolution (Fig. 
1.8a) revealed that it also has a boomerang-shaped structure with two cholesteryl 
esters and two phosphatidylcholine bound in its hydrophobic tunnel (Qiu et al., 
2007). Its potential interaction with lipoproteins is illustrated from an electron 
microscopy study (Zhang et al., 2012). It is proposed that the N-terminal β-barrel 
domain of CETP penetrates the HDL surface, and its distal end interacts with the 
cholesteryl ester core of HDL. Then, the C-terminal β-barrel domain interacts with 
LDL or VLDL. Both β-barrel domains are twisted because of the binding to form a 
tunnel, which serves as a conduit, resulting in a transfer of cholesteryl esters to LDL 





Figure 1.8 Structure and function of CETP. 4a, cartoon representation of CETP. N-terminal domain is in green 
and C-terminal domain is in yellow. 4b, proposed mechanism for cholesteryl ester transfer by CETP. The N-
terminal domain of CETP firstly penetrates the HDL surface and then its C-terminal domain interacts with 
LDL or VLDL. Those interactions result in the transfer of cholesteryl esters from HDL to LDL or VLDL. Used 
with permissions from (Qiu et al., 2007; Zhang et al., 2012). 
 
PLTP (the phospholipid transfer protein) is a main factor which regulates the size 
and composition of HDL in the bood circulation and also plays an important role in 
controlling plasma HDL levels (Huuskonen, Olkkonen, Jauhiainen, & Ehnholm, 
2001). Its regulator function is fulfiled through its phospholipid transfer activity and 
its HDL conversion ability. 
The PLUNC proteins also belong to this family. Proteins in this large group are 
predominantly expressed in the upper respiratory tract, nasal mucosa, and oral 




PLUNC) proteins and SPLUNC (short PLUNC) proteins (Canny & Levy, 2008). 
LPLUNC proteins have homology to both the N- and C-terminal domains of BPI 
and LBP, while SPLUNC proteins are only homologous to the N-terminal domain 
of BPI (Canny & Levy, 2008). Although several studies have characterized the 
expression of PLUNC proteins, their functions are still not well understood. So far, 
only the structures of SPLUNC1 from human and Latherin from horse have been 
solved (Fig. 1.9) (Ning et al., 2014; Vance, McDonald, Cooper, Smith, & Kennedy, 
2013). Both structures adopt a slightly curved cylindrical structure with a 
hydrophobic channel formed by an α/β wrap. However, neither of their ligands are 
found in their structure, although dipalmitoylphosphatidylcholine (DPPC) has 
shown to have high affinity to SPLUNC1 in vitro (Ning et al., 2014). 
 
Figure 1.9 Crystal structure of SPLUNC1 and latherin. a, cartoon representation of SPLUNC1 from human. 
Secondary structure elements are labeled.  b, cartoon representation of latherin from horse. Used with 





1.3.2 Takeout-like protein family 
This family consists of insect juvenile hormone-binding proteins and arthropod 
allergens, transporting lipid hormones to target tissues during insect development. 
JHBPs (juvenile hormone-binding proteins) from insects are responsible for the JH 
(juvenile hormone) delivery process (Kramer, Sanburg, Kezdy, & Law, 1974). 
They have high affinity and enantioselectivity for naturally occurring JHs. Recently 
the structure of JHBP from silkworm (Bombyx mori) was reported and reveals a 
possible gate and latch mechanism for hormone binding and delivery (Suzuki et al., 
2011). Comparison of the apo- and JH-bound JHBP structures (Fig. 1.10a and b) 
shows significant differences in helix α1, which is suggested to be the gate and 
controls the binding and releasing of JH. At the corpora allata cell membrane, JH 
binds to the hormone binding pocket of the apo-JHBP in the gate-open form 
followed by the closure of gate helix α1, leading to the formation of hydrogen bonds 
between the N-terminal arm and the C-terminal tail. This fully gate-closed JHBP-
JH complex will protect the bound JH from unfavourable nonspecific absorption 
and enzymatic degradation. When the complex reaches the target tissues, the bound 





Figure 1.10 Structure and function of JHBP. a, the crystal structure of JHBP in complex with JH. b, the crystal 
structure of apo-JHBP. c, the proposed mechanism for JH transport mediated by JHBP in the hemolymph. 
Used with permission from (Suzuki et al., 2011) 
 
Takeout proteins are found across a diverse range of insect species and act as ligand 
carriers. Its structure was solved at 1.3 Å initially (Fig. 1.11a), showing its TULIP 
domain consisting of a long α helix wrapped into a highly curved anti-parallel β 
sheet (Hamiaux, Stanley, Greenwood, Baker, & Newcomb, 2009). The formed 
internal cavity is 45 Å long and a ubiquinone-8 molecule is found inside, which 
might be derived from Escherichia coli. Recently, crystallography combined with 
nanoelectrospray mass spectrometry revealed a number of fatty acids (C14, myristic; 
C15, pentadecanoic; C16, palmitic; traces of C17, heptadecanoic; and C18, stearic) 
present in the internal cavity of EpTo1 when it is expressed in sf9 insect cells (Fig. 





Figure 1.11 Crystal structure of EpTo1. a, crystal structure of EpTo1 with ubiquinone-8. b, slab surface 
representation of EpTo1 with myristic acids inside the internal cavity. Used with permission from (Hamiaux et 
al., 2013). 
 
Until now, the structures of only two closely related arthropod allergens – Der f 7 
and Der p 7 – have been solved (Mueller et al., 2010; Tan et al., 2012). Those two 
proteins share 86% similarity at amino acid level and their structures all contain two 
anti-parallel β sheets which wrap around a long C-terminal helix (Fig. 1.12). The 
key difference between their structures is in the β1-β2 loop region, proximal to the 
IgE epitope in Der f 7 but not in Der p 7. Therefore, monoclonal antibody binding 
to Leu48 and Phe50 can inhibit IgE binding to Asp159 in Der f 7 due to their close 
proximity. Both allergens can weakly bind to polymyxin B via a similar binding 





Figure 1.12 Crystal structures of Der f 7 and Der p 7. a, cartoon representation of Der f 7. b, cartoon 
representation of Der p 7. Used with permissionsfrom (Mueller et al., 2010; Tan et al., 2012). 
 
1.3.3 SMP-like protein family 
This family includes subunits of the ERMES complex and the extended 
synaptotagmins (E-Syts), which appear to be mainly located at membrane contact 
sites between organelles, mediating inter-organelle lipid exchange.  
The endoplasmic reticulum-mitochondria encounter structure (ERMES) complex 
was first identified as a molecular tethering factor in the formation of ER-
mitochondrial junctions in S. cerevisiae (Kornmann et al., 2009). The ERMES 
includes four proteins – Mdm12, Mmm1, Mdm34, and Mdm10 – with different 
subcellular localizations. Mdm12 (mitochondrial distribution and morphology 
protein 12) is a cytosolic protein, while Mmm1 (maintenance of mitochondrial 
morphology protein 1) and Mdm34/10 are integral membrane proteins anchoring 




ERMES complex is to maintain a close proximity (10-30 nm) between two 
membranes; it also has functions in lipid trafficking between ER and mitochondria 
(Kopec, Alva, & Lupas, 2010; Kornmann et al., 2009; Toulmay & Prinz, 2012). A 
primary structure analysis of an ERMEs complex indicates that Mdm12, Mmm1, 
and Mdm34 all contain a synaptotagmin-like mitochondrial-lipid-binding protein 
(SMP) domain (Kopec et al., 2010). More recently, the crystal structure of Mdm12 
revealed that two Mdm12 molecules interact with each other, forming a 
hydrophobic channel to fulfil its lipid trafficking function (Jeong, Park, & Lee, 
2016). Electron density together with denaturing quantitative APCI-MS analysis 
confirmed the lipid sitting in the hydrophobic channel is PE, consistent with a 
previous study. It is proposed that Mdm12 interacts with Mdm34 in a head to head 
manner and that Mdm12 interacts with Mmm1 in a tail to tail formation. This 
hexamer is proposed to mediate the lipid transfer between ER and mitochondria 
(Fig. 1.13). 
 






E-Syts are ER-resident proteins which bring ER and PM membranes into close 
apposition (Manford, Stefan, Yuan, Macgurn, & Emr, 2012; Toulmay & Prinz, 
2012). There are three E-Syts (E-Syts1, 2, and 3) in mammalian cells, which are 
either homo- or heterodimerized (Giordano et al., 2013). Partial structures of human 
E-Syts2 (residues 163-634) have been solved recently (Schauder et al., 2014). Its 
core part, synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain, 
together with SMP domain from another E-syts2, form a 90 Å long cylinder which 
is similar to BPI and CETP. Within each SMP domain, two lipid-like molecules – 
diacylglycerol lipid and Triton X-100 – were found. Denaturing MS analysis of E-
Syts2 expressed in mammalian cells reveals the presence of glycerophospholipids 
phosphatidylcholine (PC; 67%), PE (21%), phosphatidylinositol (7%) and 
phosphatidylserine (3%), indicating a lack of specificity with respect to particular 
glycerophospholipid ligands. Based on E-Syt2’s location within the cell and its lipid 
ligands, two models were proposed to illustrate its potential function (Fig. 1.14). 
The first one is a tunnel model, which assumes the E-Syt2 dimer bridges the ER 
and PM to transfer lipids between them. E-Syt2 being anchored to the ER through 
its N-terminal region and to the PM through its C2C domain. C2A-C2B interacts 
with the membrane through loops at the ends of the arch and could interact with the 
ER, PM or either, depending on the inter-membrane distance. The second model, 
the shuttle model, may present at larger ER-PM distances compared to the tunnel 
model. In this model, the SMP dimer may shuttle lipids between the ER and PM, 





Figure 1.14 ER-PM contact site and proposed models of E-SYT2. a, schematic diagram of ER-PM contact site. 
b, the proposed tunnel model for lipid transfer. c, the proposed shuttle model for lipid transfer. Used with 
permissionfrom (Schauder et al., 2014). 
 
1.3.4 “Global” overview of TULIP superfamily 
Most proteins within the BPI-like and Takeout-like families are comprised of only 
the TULIP domain. In contrast, proteins of the SMP-like family frequently contain 
a single TULIP domain in combination with other domians that generally have 
membrane-associated activities, like PH, C2, and PDZ, and form elongated homo- 
and hetero- oligomers by end-to-end association (Alva & Lupas, 2016). Proteins 
from the Takeout-like family and SPLUNCs from the BPI-like family have a single 
TULIP domain, whilst the other proteins within BPI-like family consist of tandem 
TULIP domains forming a single chain pseudodimer. 
Overall, proteins of TULIP superfamily have four different roles based on their 
ligands (Alva & Lupas, 2016). CETP and PLTP from the BPI-like family can 
facilitate the exchange of neutral lipids (e.g., fatty acids, triglycerides, and 
cholesteryl esters) and phospholipids between lipoproteins. Proteins of SMP-like 
protein family mainly function in exchanging lipids at membrane contact sites, 
although the impairment of ERMES in yeast does not completely disrupt lipid 
exchange and does not yield a lethal phenotype. This suggests that there are other 
redundant mechanisms for lipid trafficking between the ER and mitochondria. It is 




innate immune system. Proteins of the Takeout-like family are only found in 
arthropods and they act as hormonal regulation and development. 
 
1.4 BSP30b proteins in cattle 
BSP30b has been identified as the orthologue of the human and rodent parotid 
secretory protein (PSP) (Wheeler et al., 2011). Phylogenetic analysis indicates that 
BSP30b appears to have arisen in cattle through gene duplications (Haigh et al., 
2008). BSP30b has a similar expression pattern as that of PSP from other species. 
Northern blots of BSP30b RNA indicated that expression of BSP30b is restricted 
to the major salivary glands like parotid, submandibular, sublingual and buccal 
(Wheeler et al., 2011).  
At the protein level, cattle saliva has a much higher abundance of BSP30b compared 
to PSP in human saliva (Wheeler et al., 2011). BSP30b, together with BSP30a, 
account for 15-30% of total bovine salivary proteins and can be clearly seen on SDS 
PAGE gels after Coomassie Blue staining. In contrast, the PSP in human saliva has 
a much lower concentration and is just visible on SDS PAGE gels after Coomassie 
Blue staining. Carbohydrate-specific stain (Pro-Q Emerald, Invitrogen) assay 
indicated that BSP30b, but not BSP30a, is glycosylated and it is predicted that 
BSP30b contains a mucin-type O-glycosylation site at serine 239 by using the 
NetOGlyc 3.1 predictor method (Haigh et al., 2008). Although BSP30b cannot 
interact with bacterial LPS, it still has significant antimicrobial activity against two 
out of three P. aeruginosa strains, suggesting the mechanism of its antibacterial 




The initial attempt to crystalize native BSP30b in the Arcus lab was carried out by 
Dr Judith Burrows and Dr Graeme Card in 2005. The purified BSP30b protein made 
by Judith Burrows was sent to Graeme Card at the Stanford Synchrotron for 
crystallization. BSP30b was crystallized in the optimised 24 condition matrix 
(Appendix 6), especially condition B3. Those crystals had the best diffraction to 
2.5 Å resolution, but the structure of BSP30b couldn’t be solved by the molecular 
replacement (no structure of sufficient similarity had been solved) or using 
SAD/MAD methods (no heavy atoms were introduced to the protein). 
Dr Judith Burrows also purchased genes encoding one double L-to-Met mutant and 
one triple L-to-Met mutant of BSP30b from GeneArt (Thermo Fisher Scientific, 
US), aiming to solve the structure of BSP30b using selenomethionine and 
SAD/MAD methods. Both mutants were ligated into pProEx Htb with a 6x histidine 
tag but the expression level of both proteins was poor and no crystals were produced 
after repeated experiments.    
 
1.5 Hypothesis and aims 
Although the gene expression of BSP30b has been well-studied on both mRNA 
level and protein level, its biochemical function(s) are not understood. No three 
dimensional structures of bovine PLUNC proteins have been reported. The lack of 
structural information or knowledge about their lipid substrates of the cattle 





That BSP30b is a lipid binding protein based on similar observations with 
homologues in the TULIP superfamily. More specifically, as BSP30b is abundantly 
expressed in bovine saliva and will enter the rumen together with food swallowed, 
it is hypothesised that it can bind to specific lipids within the rumen, especially the 
outer membrane lipid profile of rumen bacteria. 
1.5.2 Aims 
1. To express BSP30b in E. coli and purify the expressed protein using different 
chromatography methods. 
2. To crystallise BSP30b and determine its structure using X-ray diffraction. 




Chapter Two. Materials and Methods 
2.1 Materials and Methods Related to Chapter 3 
2.1.1 Expression and Purification of His Tagged BSP30b 
Plasmid (pTriEx 4) containing BSP30b was kindly provided by Tom Wheeler from 
AgResearch (Hamilton, New Zealand) and the plasmid was transformed into E. coli 
BL21 by a former researcher (Dr Judith Burrows) in our lab. Small scale expression 
was tested and optimised by Dr Judith Burrows; hence, only large scale expression 
of BSP30b was investigated in this thesis. 
2.1.1.1 Large Scale Expression of BSP30b with LB media 
A colony taken from an LB plate containing ampicillin was inoculated into 10 mL 
LB culture with appropriate antibiotic. The culture was grown overnight at 37 °C 
with shaking at 200 rpm. The following morning, this 10 mL culture was used to 
seed a 1 L LB culture with appropriate antibiotic in a 2 L baffled conical flask, 
which was then grown at 37 °C with shaking at 200 rpm until the OD600 reached ~ 
0.6. Protein expression was induced by adding 1 mM IPTG and growth was 
continued overnight under the same conditions. Induced cell culture was 
centrifuged at 6,000 rpm for 20 min at 4 °C and the pellet was either frozen at -
80 °C or re-suspended in 25 mL of lysis buffer (20 mM HEPES, 150 mM NaCl, 
1 mM mercaptoethanol, 20 mM imidazole, pH 8) for sonication. 
2.1.1.2 Large Scale Expression of BSP30b with Auto-induction Media 
Auto-induction media was also used for BSP30b expression. A colony taken from 




(PA-0.5G, Appendix A2) and was grown overnight at 37 °C with shaking at 200 
rpm. This 10 ml starter culture was used to seed into 1 L auto-induction media 
(ZYP-5052, Appendix A2), which was grown overnight under the same conditions. 
Induced cell culture was centrifuged at 6,000 rpm for 20 min at 4 °C and the pellet 
was either frozen at -80 °C or re-suspended in 25 mL of lysis buffer for sonication. 
2.1.1.3 Purification of His Tagged BSP30b by Immobilised Metal Affinity 
Chromatography (IMAC) 
Cells from section 2.1.1.1 or 2.1.1.2 were lysed by using a Misonix sonicator (USA) 
at a setting 4. 20 second bursts were followed by 30 second breaks for 8 times or 
until sufficient lysis. The lysed suspension was centrifuged at 13,000 rpm for 20 
min at 4 °C. The supernatant was filtered through 1 μm, 0.4 μm and 0.2 μm Minisart 
filters (Sartorius AG, Germany) consecutively. 
IMAC (Immobilised Metal Affinity Chromatoghraphy) was performed by using a 
5 mL HiTrapTM Chelating HP column (GE Healthcare, Sweden). The filtered 
supernatant was loaded onto the IMAC column, which was primed with 5 mL 
100 mM NiCl2 and equilibrated with appropriate lysis buffer (20 mM HEPES, 150 
mM NaCl, 1 mM mercaptoethanol, 20 mM imidazole, pH 8). The column was then 
attached to an ӒKTA BasicTM FPLC system which monitored protein elution by 
absorbance at 280 nm. The FPLC system was washed with MQ H2O while lines A 
and B were equilibrated in lysis buffer and elution buffer respectively before 
column attachment. The column was washed with 15 to 25 mL of lysis buffer at a 
flow rate of 1 mL/min to remove unbound proteins. Bound proteins were removed 
from column by running a gradient of 0% to 100% elution buffer (lysis buffer + 
500mM imidazole) over 80 mL at a flow rate of 1 mL/min. Fractions containing the 




was washed with either 20 ml of MQ H2O or 20 mL of 20% ethanol and stored at 4 
°C. 
2.1.1.4 SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) of Purified 
Protein 
12% SDS-PAGE gels were cast in a Hoeffer® gel casting system SE275 (Hoefer® 
Inc, USA). SDS-PAGE gels consisted of a 5 % acrylamide stacking gel overlaid on 
a 12 % acrylamide resolving gel. All gels were made with 30% acrylamide with an 
acrylamide/bis ratio of 37.5:1 (BioRad Laboratories, USA) and were polymerised 
by the addition of 0.05% (w/v) ammonium persulphate (APS) and 0.05% (v/v) 
TEMED. 
Protein samples were mixed in a 3:1 ratio with 4x SDS loading buffer (250mM Tris 
HCl pH 6.8, 20% glycerol, 4% SDS, 10% β-mercaptoethanol, 0.025% w/v 
bromophenol blue) followed by heating at 95 °C for 5 min to denature the protein. 
10 μL samples were then loaded on a SDS-PAGE gel, which was running at 50 V 
until the dye front entered the resolving gel and then running at 150 V until the dye 
front reached the bottom of the gel. 
Gel staining was following the quick coomassie blue staining method (Wong et al., 
2000). Briefly, the gel was soaked in 50 mL Fairbanks staining solution A (0.05% 
coomassie blue, 25% isopropanol, 10% acetic acid) followed by microwaving for 
30 s on full power, then the gel was shaken on a plate shaker for 5 min. After 
removing the stain, 50 mL of Fairbanks staining solution B (0.005% coomassie 
blue, 10% isopropanol, 10% acetic acid) was added and then microwaving as above. 
This was repeated for Fairbanks staining solution C (0.002% coomassie blue, 10% 




acetic acid) was poured into the box containing the gel and then shaken on a 
horizontal shaker overnight. The SDS PAGE gel was imaged by using OMEGA 
LUMTM G imaging system (Aplegen). 
2.1.1.5 Concentrating BSP30b Samples  
Fractions containing BSP30b indicated from SDS-PAGE gel results combined and 
were loaded to the upper reservoir of a 20 mL Vivaspin concentrator (Sartorius AG, 
Germany) with a molecular weight cut-off of 10,000 Dalton. The Vivaspin 
concentrator was spun at 3,000 g at 4 °C until the desired volume or concentration 
was reached. 
2.1.1.6 Concentration Measurement of BSP30b 
BSP30b has no tryptophans, and hence it has poor absorbance at 280 nm. Therefore, 
a Bradford Assay was used to measure its concentration. The PierceTM 660nm 
Protein Assay reagent (Thermo Scientific, USA) was used to measure BSP30b’s 
concentration according to the manufacturer’s instructions. Briefly, 10 μL of each 
replicate of standard (Bovine Serum Albumin Standards, Thermo Scientific) and 
serially diluted BSP30b was pipetted into a microplate well, followed by adding 
150 μL of the protein assay reagent to each well. The plate was covered with tin 
foil and mixed on a plate shaker at medium speed for 1 min and then rested at room 
temperature for 5 mins. Absorbance at 660 nm was measured by using a plate reader 
(Thermo Scientific, USA). The plotted standard curve was used to determine the 
protein concentration in Excel 2010 (Microsoft, USA). 
2.1.1.7 Purification of BSP30b by Using Size Exclusion Chromatography 
Protein was further purified by size exclusion chromatography (SEC) using a 




has a separation range of 10-600 kDa. SEC was performed on an ÄKTA BasicTM 
FPLC system, which was washed with MQ H2O prior to column attachment. The 
superdex column was equilibrated with SEC buffer (10 mM HEPES pH 8.0, 150 
mM NaCl) overnight on an ӒKTA BasicTM according to the set program. Proteins 
obtained from section 2.1.1.4 were concentrated to 2 mg/mL and filtered with a 
0.2 μm filter before loading onto the superdex column. Proteins were eluted with 
SEC buffer according to their size. Fractions containing the desired protein were 
then analysed by SDS-PAGE and concentrated using a 20 mL Vivaspin 
concentrator for further purpose. 
Calibration of SuperdexTM 75 16/60 GL SEC column was performed using the high 
and low molecular weight gel filtration calibration kits (GE Healthcare, Sweden) 
according to the manufacturer’s instructions. The molecular weights of unknown 
proteins were calculated from calibration curves based on proteins of known 
molecular weights. The curves were prepared by plotting retention volume data 
(Kav) against the logarithm of the molecular weights of the calibration kit proteins. 
The molecular weights of unknown proteins can be determined from the curve 
together with calculated correlation and variance. 
2.1.2 Generation, Expression and Purification of 
BSP30b_F52M_F106M 
2.1.2.1 Synthesis of BSP30b_F52M_F106M gene 
As BSP30b does not contain any methionine, two methionine sites (F52M, F106M) 
were introduced into the protein sequence for SAD (single-wavelength anomalous 
dispersion) studies. DNA sequence coding BSP30b_F52M_F106M with restriction 




synthesized by GeneArt (Life Technologies, Carslbad CA). The synthesized 
sequence was initially inserted into plasmid pMA-T. 
 
 
Figure 2.1 Plasmid map of pMA-T with the synthetic gene BSP30b_F52M_F106M inserted. Restriction sites 
BamHI and XhoI were designed at its N and C terminal, respectively. 
 
2.1.2.2 Preparation of Electrocompetent E. coli BL21 Cells 
A glycerol stock of E.coli BL21 cells was streaked onto a low salt LB plate and 
incubated at 37 °C overnight. On the second afternoon, a single colony was 
inoculated into a 10 mL low salt LB starter culture and grown overnight at 37 °C 
with shaking at 200 rpm. One microliter of this starter culture was then used to 
inoculate 1 L of low salt LB, which was grown at 37 °C with shaking at 200 rpm to 
an OD600 of around 0.7. The cells were then chilled on ice for 1.5 hours followed 
by centrifugation at 4,000 g for 20 mins at 4 °C. After discarding the supernatant 
immediately, the cell pellet was gently re-suspended in 100 mL of ice cold sterile 
10% glycerol and centrifuged again at the same conditions as above. The 




sterile 10% glycerol. 50 μL aliquots were flash frozen in liquid nitrogen and stored 
at -80 °C. 
2.1.2.3 Electroporation of Customised Plasmid into E. coli BL21 
Lyophilized plasmid from GeneArt was initially re-suspended in 50 μL distilled 
water, 1 μL of which was added into 50 μL of freshly thawed electrocompetent E. 
coli BL21 cells on ice. The mixture was then transferred into a 0.2 cm 
electroporation cuvette (Bio-Rad Laboratories, USA). Electroporation was 
undertaken with a Bio-Rad Gene PulserTM (Bio-Rad Laboratories, USA) with 
settings 2.5 kV, 25 μF capacitance, and 200 Ω resistance. After electroporation, 1 
mL of SOC medium was immediately added into transformed mixture and 
transferred into a 1.5 mL Eppendorf tube followed by shaking incubation at 37 °C 
for 1 hr. After incubation, 100 μL of the culture was spread on a LB agar plate 
containing ampicillin (100 μg/mL). The remaining culture was centrifuged at 
13,000 rpm for 1 min and the pellet was re-suspended in 100 μL LB medium, which 
was then spread on another LB agar plate containing ampicillin. The plates were 
incubated at 37 °C overnight. 
2.1.2.4 Primer Design for PCR 
In order to confirm the success of transformation of plasmid pMA-T into E. coli 
BL21, primers for amplification of the BSP30b_F52M_F106M were designed and 
analysed using Geneious 7.1.5 (Biomatters Ltd, Auckland). Primers were supplied 
by IDT (Coralville, IA) and were re-suspended in 1x TE buffer (10 mM Tris-HCl, 
1 mM EDTA; pH 8.0) to a concentration of 100 μM as stock kept in -20 °C freezer 




2.1.2.5 Colony PCR (polymerase chain reaction) Amplification of 
BSP30b_F52M_F106M 
To confirm the success of cloning in section 2.1.2.3, five randomly selected 
colonies were re-suspended in 10 μL of MQ H2O, respectively. 1 μL from each 
dilution was used as template for PCR using gene specific primers (Table 2.1). HOT 
FIREPol® DNA polymerase (SOLIS BIODYNE, Estonia) was used for the 
amplification of gene insert. PCR reactions were carried out in 25 µL volumes. The 
reagents and their concentrations for PCR were list in table 2.2 and the cycling 
conditions were described in table 2.3. 
Table 2.1 primers used for transformation confirmation of BSP30b_F52M_F106M into E. coli BL21 
 Primer sequence Tm 
BSP30b_DM_F CTGGTTCTGCTGTGTGGTCT 64.4 °C 
BSP30b_DM_R ACTTCTGAGTTCGGCATGGG 64.5 °C 
 
Table 2.2 PCR reaction components for amplification 
Components Concentration 
DNA Template ~100 ng 
HOT FIREPol® polymerase 2.5 U  
PCR Buffer 1X 
MgCl2 1.5 mM 
dNTPs 0.2 mM 





Table 2.3 PCR conditions for amplification 
Hot start 95 °C 15 min 






Final extension 72 °C 10 min 
 
2.1.2.6 Agarose Gel Electrophoresis 
PCR amplified DNA from section 2.1.2.5 was separated via agarose gel 
electrophoresis for visualisation. Samples mixed with 5 x DNA loading dye were 
running on a 1% agarose gel (made with SYBR SafeTM DNA dye) in 1 x TAE buffer 
at 90 V for 20 min. PCR amplicons were visualised under UV light and their sizes 
were determined by comparison against 1 kb+ DNA ladder (Invitrogen). 
2.1.2.7 Plasmid DNA Extraction  
Colony confirmed containing gene insert was sub-cloned on a LB agar plate 
containing ampicillin. A 10 mL culture of the sub-cloned cells was grown overnight 
at 37 °C with shaking at 200 rpm. For plasmid DNA extraction, Qiagen Miniprep 
Kit (Qiagen, Netherlands) was used for plasmid extraction following the 
manufacturer’s instructions and eluted in 30 – 50 µL of elution buffer depending 




2.1.2.8 DNA Quantification 
DNA concentration was measured by using a Nanodrop ND-1000 
spectrophotometer (Nanodrop technologies, USA). In short, the spectrophotometer 
was first blanked with 2 μL of elution buffer and then 2 μL of DNA sample was 
loaded on the machine. The concentration of DNA was determined by its 
absorbance at 260 nm. 
2.1.2.9 Cloning of BSP30b_F52M_F106M into pProEx Htb 
pProEx Htb is a bacterial expression vector with ampicillin resistance. Plasmid 
pProEx Htb was minipreped as described in section 2.1.2.7. 
2.1.2.9.1 Restriction Enzyme Digestion 
Restriction enzymes were purchased from Invitrogen (USA). pProEx Htb and 
purchased plasmid were digested separately with restriction enzymes BamHI and 
XhoI. In short, restriction enzyme digestion was performed in a final volume of 
30 μL using the appropriate buffer as recommended by the manufacturer, at 37 °C 
for 4 hours with shaking at 400 rpm on a thermomixer (Eppendorf, Germany). The 
reaction was performed with 20 U of each enzyme and 1000 ng of DNA. 
Digested DNA was separated on a 1% agarose gel as described in section 2.1.2.6. 
The desired bands were extracted from agarose gel using a sterile scalpel blade and 
DNA was purified using a High Pure PCR Product Purification Kit (Roche Applied 
Science, Switzerland) or QIAquick Gel Extraction Kit (Qiagen, Netherlands) 
following the manufacturer’s recommendations. DNA was eluted in 30 - 50 μL of 
elution buffer and its concentration was determined by using NanoDrop as 




2.1.2.9.2 DNA Ligation 
DNA ligation was performed with 0.1 unit of T4 DNA Ligase (Invitrogen, USA) in 
20 μL reaction according to the manufacture’s protocol with slight changes. The 
ligation was carried out as illustrated in table 2.3. 
Table 2.4 Ligation reaction components and conditions 
5x Ligase Reaction Buffer 4 μL 
Insert: Vector Molar Ratio 3:1 
Vector Ends 30 fmol 
Insert Ends 90 fmol 
T4 DNA Ligase 0.1 unit 
Autoclaved distilled water To 20 μL 
Temperature  4 °C 
Time  overnight 
 
On the second day, 2 µL of this ligated reaction was transformed into E. coli BL21 
following the method as per 2.1.2.3. The transformation success of new plasmid 
construct was assessed by PCR amplification using primers in table 2.1 and agarose 
gel electrophoresis as described in section 2.1.2.5. 
2.1.2.10 DNA Sequencing 
The new plasmid construct was also sequenced by Massey Genome Service (MGS) 
using Sanger sequencing on an ABI3730 DNA Analyzer (Applied Biosystems, 




analysed by using Geneious 7.1.5 (Biomatters, Auckland) to confirm correct 
insertion. 
2.1.2.11  Glycerol Stock Preparation  
Glycerol stocks were made for long term storage of transformed strains. In short, 
0.5 mL of fresh bacterial culture was mixed with 0.5 mL of 50% glycerol in a 2 mL 
storage tube, which was then placed into -80°C freezer. 
2.1.2.12 BSP30b_F52M_F106M Expression Trial in M9 Minimal Media 
Selenomethionine (SeMet) incorporated protein was expressed in E. coli BL21 
using the methionine pathway inhibition method (Hendrickson et al., 1990). 
Methionine biosynthesis was blocked by inhibiting aspartokinases in the presence 
of a high concentration of isoleucine, lysine, and threonine. This allows the 
incorporation of SeMet when it is added into the growth media. 
The expression ability of BSP30b_F52M_F106M in M9 minimal media (Appendix 
A2) was tested before the incorporation of selenomethionine (SeMet). A single 
colony of the transformed E. coli BL21 was inoculated into 10 mL of LB media 
with appropriate antibiotic and grown overnight at 37 °C with shaking at 200 rpm. 
On the second day morning, the culture was centrifuged at 4,600 rpm for 10 min 
and the cell pellet was re-suspended in 1 mL of M9 minimal media. This culture 
was used to inoculate 1 L of M9 minimal media with appropriate antibiotic and 
grown at 37°C with shaking at 200 rpm. When the OD600 of the culture reached 0.4-
0.6, 100 mg each of lysine, phenylalanine and threonine, 50 mg each of isoleucine 
and valine, 60 mg of methionine were added and the growth was continued for a 
further 15 min. 0.5 mM IPTG was added for protein induction and the culture was 




4 °C and the pellet was either frozen at -80 °C or re-suspended in 25 mL of lysis 
buffer (20 mM HEPES, 150 mM NaCl, 1 mM mercaptoethanol, 20 mM imidazole, 
pH 8) for sonication.  
BSP30b_F52M_F106M was first purified by IMAC using a 5 mL HiTrapTM 
Chelating HP column as per 2.1.1.3. Fractions containing the protein of interest 
were analysed by SDS PAGE and the protein expression level was determined from 
the SDS PAGE gel result.  
BSP30b_F52M_F106M was further purified with SEC using a SuperdexTM 200 
10/300 GL column as per 2.1.1.7. Fractions of interest were analysed by SDS PAGE 
and protein was concentrated using a 20 mL Vivaspin concentrator for further 
purpose. 
2.1.2.13 Incorporation of Selenomethionine (SeMet) into 
BSP30b_F52M_F106M 
The procedure to express SeMet incorporated protein is similar to the expression 
trial in minimal media as per 2.1.2.12. The only difference is that instead of using 
60 mg of methionine, 60 mg of selenomethionine was added to the media. Induced 
cell culture was centrifuged at 6,000 rpm for 20 min at 4 °C and the pellet was either 
frozen at -80 °C or re-suspended in 25 mL of lysis buffer (20 mM HEPES, 150 mM 
NaCl, 1 mM mercaptoethanol, 20 mM imidazole, pH 8) for sonication. 
2.1.2.14 Purification of BSP30b SeMet derivative 
Protein was first purified by IMAC using a 5 ml HiTrapTM Chelating HP column as 





An anion exchange chromatography step was added after IMAC to improve the 
purity of BSP30b SeMet derivative. Anion exchange chromatography was 
performed using a Mono Q anion exchange column (GE Healthcare) on ÄKTA 
BasicTM HPLC system. Briefly, the Mono Q anion exchange column was 
equilibrated with 10 ml of buffer A (20 mM HEPES pH 7.5, 50 mM NaCl, 0.1 mM 
EDTA) and then the concentrated BSP30b_F52M_F106M SeMet derivative was 
loaded into the sample loop. Proteins were eluted from column by running a 
gradient of 0% to 100% buffer B (20 mM HEPES pH 7.5, 0.1 mM EDTA, 600 mM 
NaCl) over 80 mL at a flow rate of 1 mL/min. Fractions containing the desired 
protein were then analysed by 12% SDS-PAGE.  
Protein was further purified with SEC using a SuperdexTM 200 10/300 GL column 
as per 2.1.1.7. Purified protein was analysed by SDS PAGE and concentrated using 
a 20 mL Vivaspin concentrator for further purpose. 
2.1.3 Expression and Purification of MBP Fused 
BSP30b_F52M_F106M 
2.1.3.1 Cloning of BSP30b_F52M_F106M into pMAL-c2X 
The BSP30b_F52M_F106M gene was cloned into the maltose binding protein 
fusion tag E. coli expression vector pMAL-c2X (New England Biolabs, USA) as 
follows. The BSP30b_F52M_F106M gene was amplified from the pMA-T vector 
via PCR using forward and reverse primers (Table 2.5) containing the restriction 





Table 2.5 Primers used for cloning of BSP30b_F52M_F106M into pMAL-c2X 
 Primer sequence Tm 
BSP30b_DM_F CTGGTTCTGCTGTGTGGTCT 64.4 °C 
pBAD_R GATTTAATCTGTATCAGG 49.7 °C 
 
Purified PCR product and miniprepped pMAL-x2X plasmid were digested with 
restriction enzymes BamHI and PstI, respectively. After gel electrophoresis and 
purification, both digested products were ligated and then transformed into E. coli 
BL21 as per 2.1.2.9. The success of cloning was confirmed by colony PCR using 
primers in table 2.5 and agarose gel electrophoresis. Glycerol stocks of transformed 
strains were made for long term storage. 
 
2.1.3.2 Large Scale Expression and Purification of MBP Tagged 
BSP30b_F52M_F106M 
A 10 mL culture of BSP30b_F52M_F106M-pMAL-c2X in E. coli BL21 in LB 
media with ampicillin (100 μg/mL) and glucose (2 g/L) was grown overnight at 37 
°C with shaking at 180 rpm. This culture was used to inoculate 1 L of fresh pre-
warmed LB media with ampicillin (100 μg/mL) and glucose (2g/L), which was then 
grown at 37 °C, shaking at 180 rpm until it reached an OD600 of 0.4 – 0.6. Protein 
expression was induced by adding IPTG to a final concentration of 1 mM and 
growth was continued at 37 °C overnight with shaking at 180 rpm. The culture was 
pelleted by centrifugation at 6,000 rpm for 20 minutes at 4 °C, and re-suspended in 




Complete Mini EDTA-free protease inhibitor cocktail tablet added (Roche 
Diagnostics, USA) prior to cell lysis. Cells were lysed on ice using a sonicator® 
ultrasonic processor XL fitted with a flat probe at level 4 for 8 x 20 seconds 
(Misonix Incorporated, USA). After sonication, the sample was centrifuged for 20 
minutes at 13,000 rpm at 4 °C to pellet the cell debris. The supernatant was filtered 
through 1.2 μm, 0.45 μm, and 0.2 μm Minisart syringe filters (Sartorius AG, 
Germany) prior to protein purification. 
A 5 mL MBP Trap™ HP column (GE Healthcare, Sweden) was prepared by 
washing with 10 mL MQ H2O and equilibrating with 15 mL of lysis buffer. The 
filtered supernatant was then loaded onto the column using a syringe and the 
column was attached to an ÄKTA Basic™ FPLC system which monitors protein 
elution by absorbance at 280 nm. The FPLC system was washed with MQ H2O and 
lines A and B equilibrated in lysis buffer and elution buffer (20 mM HEPES pH 
7.5, 200 mM NaCl, 1 mM EDTA, 10 mM maltose) respectively prior to column 
attachment. At a flow rate of 1 mL/min, the column was washed with 50 mL of 
lysis buffer to remove unbound proteins and then bound proteins were eluted with 
25 mL of 100% elution buffer. Fractions containing protein of interest were 
analysed by 12 % SDS-PAGE. After use, the MBP Trap™ HP column was 
regenerated by washing with 10 mL of 0.1% SDS, and 20 mL of MQ H2O and 
rinsed with 10 mL of 20% ethanol for storage at 4 °C. 
Protein was further purified with SEC using a SuperdexTM 200 10/300 GL column 
as described in 2.1.1.7. The purified protein was analysed by SDS PAGE and 




2.2 Materials and Methods Related to Chapter 4 
2.2.1 Crystallization Trials for BSP30b 
2.2.1.1 Robotic Crystallization Screens of BSP30b 
Concentrated protein after SEC purification was subjected to robotic crystallisation 
screens, which were performed using the high throughput Mosquito® crystal robot 
screening system (TTP Labtech Ltd, UK). Sitting drop vapour diffusion method 
was performed with PEGRx HT, Index HT, Crystal Screen HT, and SaltRx HT 
crystallisation screens (Hampton Research, Aliso Viejo CA). 100 μL of each 
condition was dispensed into 96 well Intelli-plate (Hampton Research) reservoirs 
manually and then 100 nL of protein and reservoir solutions were robotically loaded 
into the crystallisation well respectively. All Intelli plates were sealed with 
ClearSealTM film (Hampton Research) and stored at 18 °C for crystal growth. All 
of the crystallisation wells were checked routinely for crystal “hits” using a bench 
top microscope. 
2.2.1.2 Fine Screen of Native BSP30b 
Conditions showing crystal “hits” from robotic screening were chosen for fine 
screens, which were performed using hanging drop vapour diffusion method in 24 
well plates (Hampton Research). 500 μL of robotic screen condition solution, which 
is also called ‘mother liquor’, was pipetted into a well. 1 μL of protein and 1 μL of 
‘mother liquor’ were mixed on a 22 mm square siliconized coverslip (Hampton 
Research), which was then inverted over the same well and sealed by grease 
(Glisseal N). The plate was left on a steady shelf at 18 °C and was checked routinely 




Conditions optimised by modifying the pH, crystallisation component 
concentrations were also set up for fine screens. Fine screens using conditions 
(Appendix A6) from former study of BSP30b in Vic Arcus’ lab were also set for 
crystallization. 
2.2.1.3 Additive Screen 
Additive screens based on the most promising conditions ware performed using the 
high throughput Mosquito® crystal robot screening system as mentioned above. 
Commercial reagent (Additive Screen HT) purchased from Hampton research was 
used. Conditions having crystal “hits” were reproduced with fine screen. 
2.2.1.4 Silver Bullet Screen 
Silver bullet screen based on the most promising conditions ware performed using 
the high throughput Mosquito® crystal robot screening system as mentioned above. 
Commercial reagent (Silver Bullets) purchased from Hampton research was used. 
Conditions having crystal “hits” were reproduced with fine screen. 
2.2.1.5 Trypsin Digestion 
In situ proteolysis using trypsin for crystallization of BSP30b was set up, intending 
to improve crystal quality. Trypsin digestion of BSP30b was tested at room 
temperature within a 1.5 mL Eppendorf tube. Trypsin from bovine pancreas (Sigma 
Aldrich, St. Louis MO) was added to BSP30b at ratio of 1 mg:100 mg and 20 μL 
of this mixture was pipetted into a new Eppendorf tube containing 5 μL of SDS 
PAGE loading dye after 15s, 30s, 1 min, 5 min, 10min, 1 hr, and 4 hr, respectively. 
Notably, those new Eppendorf tubes containing digested BSP30b were immediately 
heated at 95 °C for 5 mins on a thermomixer after each incubation in order to 




12 % SDS PAGE gel and stained with coomassine (detailed protocol in section 
2.1.1.4). The best digestion time was determined from this gel result. 
To set up the crystallization trial after digestion, the proper amount of trypsin was 
added to the protein. After the optimised digestion time, fine screen was 
immediately set for crystallization. Crystallization progress was monitored and 
recorded routinely. 
2.2.1.6 Streak Seeding 
Streak seeding is a method to introduce pre-formed crystal nuclei into a fine screen 
drop with a cat whisker. The fine screen was set normally as described in section 
2.2.1.2 and pre-equilibrated for 2-3 hr before seeding. A cat whisker was streaked 
through an existing crystal drop and then the cat whisker was run through the pre-
equilibrated drop starting from outside the drop and ending outside the drop in a 
smooth motion. The cat whisker was rinsed with 70% ethanol before seeding a 
different drop. Crystallization progress was monitored and recorded routinely. 
2.2.1.7 Batch Seeding 
To prepare the seed stock, 2 μL of the crystal drop was added into 18 μL of mother 
liquor in an Eppendorf tube and crystals were crushed with vortex. Those crushed 
crystals were serially diluted 10,000 times and the final diluted one was used as the 
seed stock. The hanging drop of fine screen was set up with 1 μL of BSP30b and 1 





2.2.1.8 Heavy Metal Soaks  
In order to solve the phase problem, selected crystals from fine screens were soaked 
in heavy metal solutions in order to obtain anomalous signal during X-ray 
diffraction experiments. The binding ability of several heavy metals to BSP30b was 
determined by using a native PAGE gel shift method (Boggon & Shapiro, 2000). 
The casting of native PAGE gel is similar to SDS-PAGE gel (section 2.1.1.4). The 
only difference is that SDS is not added to make native PAGE gel. To perform the 
gel shift assay, 5 μL of each heavy metal compound (HgAC, HgBr2, Hg(CN)2, 
KAu(CN)2, K2PtCl4, K2PtCl6, HgCl2) at concentrations of 10 mM was added to 20 
μL of BSP30b solution, respectively. 10 μL of each mixture or BSP30b itself 
together with 2 μL of 5x native gel loading dye (300 mM Tris-HCl pH 6.8, 50% 
(v/v) glycerol, and 0.05% (w/v) bromophenol blue) was run on a 12 % native PAGE 
gel. Those heavy metal compounds whose mixture with BSP30b having shifted 
bands compared to BSP30b itself on native PAGE gel will be used for crystal 
soaking experiment. 
Crystal soaking was performed with a 24 well fine screen plate. 5 μL of mother 
liquor containing 2 mM of heavy metal was pipetted on a cover slip and BSP30b 
crystals were looped into the drop. The cover slip was inverted on a well having 
500 μL of mother liquor and sealed with grease for 2 days. Those crystals were 
frozen in liquid nitrogen without cryo-protectant and taken to Australian 




2.2.2 X-ray Diffraction and Data Analysis of BSP30b Crystals 
2.2.2.1 Crystal X- ray Diffraction Testing 
X-Ray diffraction testing of crystals was performed on an Agilent Supernova X-
Ray Diffractometer (Agilent Technologies, Liberty Lake WA) at the University of 
Waikato using a Titan S2 CCD detector. Home source X-Rays were generated using 
CuKα radiation from a sealed source generator and reflections were detected using 
a CCD detector. In order to reduce radiation damage to crystals, crystals were 
soaked into a cryo-protectant (crystallization conditions + 30% PEG 400) before 
mounting on the X-Ray diffractometer. The cryo-protectant itself was tested first 
for X-Ray diffraction to detect if any ice rings were formed which would interfere 
with the diffraction results of protein crystals. 
2.2.2.2 X-ray Diffraction Data Collection for BSP30b at the Australian 
Synchrotron  
Crystals of BSP30b from fine screens were initially flash-frozen in liquid nitrogen 
with cryo-protectant (crystallization conditions + 30% PEG 400) prior to data 
collection at the Australian Synchrotron. BSP30b crystals tended to crack when 
transferred from mother liquor to cryo-protectant, and hence crystals were flash-
frozen in liquid nitrogen without cryo-protectant during all of the following 
experiments.  
Data were collected at the macromolecular crystallography beamline (MX1 or MX2) 
at the Australian Synchrotron using an ADSC Quantum 210r detector. 
Crystals having diffraction better than 3 Å at initial shot were chosen for further 
data collection. 360° of data were collected using individual images with an 




2.2.2.3 General Data Processing for Native BSP30b 
The dataset was indexed and integrated in iMosfilm (Leslie & Powell, 2007) to 
integrate the reflections and to determine the unit cell parameters in the CCP4 
platform suite 6.4.0 (Collaborative Computational Project, 1994). Briefly, two 
images that were 90 degrees apart in Phi were used to search for differaction spots. 
Autoindexing was then carried out to determine space group and cell paramaters. 
The cell parameters were further refined by Cell Refinement to obtain more 
accurate cell parameters. The distribution of the intensities of partially recorded 
reflections over the images on which they occur was used to refine the unit cell, 
crystal orientation and mosaic spread. All of the images were integrated into an mtz 
file to produce a list of reflection intensities.  
The output mtz file from iMosfilm was then scaled and truncated using Aimless 
(Evans & Murshudov, 2013). The programme Pointless was used first to determine 
the point-group symmetry the likely space group. The programme Aimless was then 
used to scale symmetry related intensities and produce statistics on data quality. 
Ctruncate was executed to calculate the structure amplitudes |F| from the intensities 
and to output various diagnositic statistics, for example to detect twinning. The 
newly created file was examined for unfavoured Rmerge, I/σ(I) and data 
completeness and rescaled to improve these parameters if necessary. 
In order to determine the number of BSP30b molecules in the ASU and the solvent 
content of the unit cell, Matthews_coeff in the CCP4 platform was used. The scaled 
mtz file from Aimless together with the molecular mass of BSP30b were used to 




2.2.2.4 X-ray Diffraction Data Collection for Heavy Metal Soaked BSP30b  
Heavy metal soaked BSP30b crystals were flash-frozen in liquid nitrogen with or 
without cryo-protectant. Data were collected at the macromolecular crystallography 
beamline MX2 at the Australian Synchrotron using an ADSC Quantum 210r 
detector. Crystals having diffraction better than 3.5 Å resolution at the initial shot 
were chosen for further data collection. 360 diffraction images were collected with 
oscillation of 1 degree. 
2.2.2.5 General Data Processing for Heavy Metal Soaked BSP30b 
The dataset was indexed and integrated in iMosfilm to integrate the reflections and 
to determine the unit cell parameters in the CCP4 platform suite 6.4.0. The output 
mtz file from iMosfilm was then scaled and truncated using Aimless. This new 
created file would be examined by eye for unfavoured Rmerge, I/σ(I) and data 
completeness and rescaled to improve these parameters if necessary. Anomalous 
signal was checked from the Aimless log file. 
2.2.3 Crystallization Trials for His Tagged BSP30b_F52M_F106M 
Concentrated BSP30b_F52M_F106M after SEC purification was subjected to 
robotic crystallisation screens followed the instructions in 2.2.1.1. All of the 
crystallisation wells were checked for crystal “hits” routinely. Fine screen will be 
set with those conditions having crystal “hits”. 
Fine screens of BSP30b_F52M_F106M were also laid down with the old 24 
conditions as per 2.2.1.2. Crystallization progress was monitored and recorded 
routinely. Crystals from fine screen were frozen in liquid nitrogen and taken to 




2.2.4 X-ray Diffraction and Data Analysis of 
BSP30b_F52M_F106M Crystals 
2.2.4.1 His Tagged BSP30b_F52M_F106M X-ray Diffraction Experiment 
at Australian Synchrotron 
Crystals were flash frozen in liquid nitrogen without cryo-protectant and data were 
collected at the macromolecular crystallography beamline MX2 at the Australian 
Synchrotron using an ADSC Quantum 210r detector. 
In order to capture the anomalous signal generated from selenium, a special 
wavelength of X-ray (0.9537 Å, just below the K shell absorption edge of selenium) 
was chosen for data collection. Crystals having diffraction better than 2.5 Å at initial 
shot were chosen for further data collection. 360 diffraction images were collected 
with oscillation of 1 degree. 
2.2.4.2 General Data Processing 
The dataset obtained from Australian Synchrotron was processed as per 2.2.2.3. 
2.2.4.3 Phase Determination 
The re-scaled mtz files were input into AutoSol (Terwilliger et al., 2009) within the 
PHENIX platform (Adams et al., 2011) for searching heavy atom sites, 
experimental phases, and model-building. Heavy atom selenium was added into the 
input file interface of AutoSol to help the phase processing. 
2.2.4.4 Model Building and Refinement 
Initial structure was built using AutoBuild (Terwilliger et al., 2008) with phases 
from AutoSol. The structure was then refined using phenix.refine (Afonine, Grosse-




model building using COOT 0.7 (Emsley & Cowtan, 2004) and refinement in 
phenix.refine were performed until the R free could not be improved. 
2.2.5 Crystallization of MBP Tagged BSP30b_F52M_F106M 
2.2.5.1 Robotic Crystallization Screens 
Concentrated protein after SEC purification was subjected to robotic crystallisation 
screens, which were performed using the high throughput Mosquito® crystal robot 
screening system (TTP Labtech Ltd, UK). Sitting drop vapour diffusion method 
was performed with PEGRx HT, Index HT, Crystal Screen HT, and SaltRx HT 
crystallisation screens (Hampton Research, Aliso Viejo CA) as per 2.2.1.1. 
Crystallization progress was monitored routinely and the conditions showing 
crystal “hits” were reproduced with fine screen. 
2.2.5.2 Fine Screen 
Fine screens of MBP tagged BSP30b_F52M_F106M was also performed with the 
old 24 conditions as in 2.2.1.2. Crystallization progress was monitored and recorded 
routinely. Crystals were frozen in liquid nitrogen and taken to Australian 
Synchrotron for X-ray diffraction experiment.  
2.2.6 X-ray Diffraction and Data Analysis of MBP Tagged 
BSP30b_F52M_F106M 
2.2.6.1 MBP Tagged BSP30b_F52M_F106M X-ray Diffraction 
Experiment at Australian Synchrotron 
Data was collected at the macromolecular crystallography beamline MX2 at the 




diffraction better than 3 Å at initial shot were chosen for further data collection. 360 
diffraction images were collected with oscillation of 1 degree. 
2.2.6.2 General Data Processing for MBP Fused BSP30b_F52M_F106M 
The dataset was indexed and integrated in iMosfilm to integrate the reflections and 
to determine the unit cell parameters in the CCP4 platform suite 6.4.0. The output 
mtz file from iMosfilm was then scaled and truncated using Aimless. This new 
created file would be examined by eye for unfavoured Rmerge, I/σ(I) and data 
completeness and re-scaled to improve these parameters if necessary. 
Phase information was derived using molecular replacement method. Specifically, 
the scaled file was input into Phaser-MR (McCoy et al., 2007) within PHENIX 
platform. The pdb files of MBP (PDB code: 4MBP or 1ANF) or the pdb file of the 
solved BSP30b in this study was used as the search model for molecular 
replacement. The generated structure was then refined using phenix.refine in 
PHENIX platform. Subsequent cycles of manual refinement using COOT 0.7 and 
refine in phenix.refine were performed until the R free dropped to the desired value. 
2.3 Materials and Methods Related to Chapter 5 
2.3.1 Expression and Purification of BSP30b_F52M_F106M with 
Its Potential Ligands 
Since better quality crystals were produced by BSP30b_F52M_F106M, this mutant 
was used for crystallization with potential ligands. Protein expression was 
conducted in LB media.  
A colony taken from an LB plate containing ampicillin was inoculated into 10 mL 




with shaking at 200 rpm. The following morning, this 10 mL culture was used to 
seed a 1 L LB culture with appropriate antibiotic in a 2 L baffled conical flask, 
which was then grown at 37 °C with shaking at 200 rpm until the OD600 reached ~ 
0.6. Protein expression was induced by adding 1 mM IPTG and growth was 
continued overnight under the same conditions. Induced cell culture was 
centrifuged at 6,000 rpm for 20 min at 4 °C and the pellet was either frozen at -
80 °C or re-suspended in 25 mL of lysis buffer (20 mM HEPES, 150 mM NaCl, 
1 mM mercaptoethanol, 20 mM imidazole, pH 8) for sonication. 
Protein was first purified by IMAC using a 5 ml HiTrapTM Chelating HP column as 
per 2.1.1.3. Fractions containing protein of interest were analysed by 12% SDS 
PAGE. 
Protein was further purified by anion exchange chromatography and SEC as per 
2.1.2.14. Purified protein was then concentrated to 2 mg/mL 20 μL of either 
linolenic acid, ethyl linoleate, glycerol monolinoleate, or oleic acid (Fig. 2.2) was 
added to protein solution and this mixture was incubated at 4 °C overnight. On the 
second day, this mixture was purified again with SEC on ÄKTA BasicTM using 
SuperdexTM 200 10/300 column to remove the extra lipid. Fractions from SEC were 






Figure 2.2 Fatty acids used for co-crystallization. Linolenic acid, ethyl linoleate, glycerol monolinoleate, and 
oleic acid were used to co-crystallize with BSP30b mutant separately. 
 
2.3.2 Crystallization of BSP30b mutant with Potential Ligands 
BSP30b mutant purified from 2.3.1 with different fatty acids was concentrated and 
fine crystallization screens were set up separately using the old 24 crystallization 
conditions (Appendix A6). Crystallization progress was monitored and recorded 
routinely. Crystals were flash-frozen in liquid nitrogen without cryo-protectant and 
taken to Australian Synchrotron for X-ray diffraction experiment. 
2.3.3 X-ray Diffraction and Data Analysis of BSP30b Mutant with 
Potential Ligands 
2.3.3.1 X-ray Diffraction Experiment at Australian Synchrotron of 
BSP30b_F52M_F106M with Potential Ligands 
Crystals were flash-frozen in liquid nitrogen without cryo-protectant. Data was 




Synchrotron using an Eiger 16M detector. Crystals having diffraction better than 
2.5 Å at initial shot were chosen for further data collection. 3600 diffraction images 
were collected with 0% attenuation, oscillation of 0.1 degree in 36 seconds. 
2.3.3.2 Structure Determination 
The scaled file obtained from Australian Synchrotron was examined by eye for 
unfavoured Rmerge, I/σ(I) and data completeness, and rescaled to improve these 
parameters if necessary. 
The rescaled mtz file was subjected to molecular replacement. Molecular 
replacement was performed using Phaser-MR in PHENIX platform with the solved 
BSP30b structure as the reference model.  
The structure model was manually refined in COOT with the 2mFo-dFc electron 
density map contoured at 1 sigma. Ligand searched from the monomer library was 
manually fitted into the empty positive electron density contour. Several rounds of 
refinement using phenix.refine in PHENIX and manual refinement in COOT was 
performed until the R free dropped to the desired value. 
2.3.4 Cloning of BSP30b and GFP into Plasmid pProEx Htb 
In order to create fused GFP_BSP30b construct, sfGFP and BSP30b were cloned 
into pProEx Htb sequentially.  
sfGFP in plasmid pIM1773 (kindly given by Dr Jo Hicks) was used for this 
experiment. sfGFP sequence was amplified with primers containing BamHI and 
PstI restriction digestion sites (Table 2.6). Purified PCR product and pProEx Htb 
plasmid were digested with restriction enzymes BamHI and PstI, respectively. After 




transformed into E. coli BL21 as per 2.1.2.9. The success of cloning was confirmed 
by colony PCR. Glycerol stocks of transformed strains were made for long term 
storage. 
Table 2.6 primers used for cloning of GFP into pProEx Htb 
 Primer sequence Tm 
GFP_F GGTGGTGGATCCGGCTCCAAAGGCGAGGAA 72.7 °C 
GFP_R GGTGGTCTGCAGCTTGTATAATTCATCCAT 60.3 °C 
 
The cloning of BSP30b into pProEx Htb_GFP will follow the same procedures. 
BSP30b sequence was amplified with primers containing XhoI and hindIII 
restriction sites (Table 2.7). Purified PCR amplicon and pProEx Htb_sfGFP were 
digested with XhoI and hindIII, respectively. After gel electrophoresis and 
purification, both digested products were ligated and then transformed into E. coli 
BL21.The success of cloning was confirmed by colony PCR. Glycerol stocks of 
transformed strains were made for long term storage. 
Table 2.7 primers used for cloning of BSP30b_F52M_F106M into pProEx Htb 
 Primer sequence Tm 
BSP_XhoI GGTGGTCTCGAGGGAGCCTGCCGGATATTCGTG 70.4 °C 





2.3.5 Large Scale Expression and Purification of His Tagged 
GFP_BSP30b 
2.3.5.1 Large Scale Expression of GFP_BSP30b 
The expression of GFP_BSP30b in 1 L LB media was carried out in large scale as 
described in 2.1.1.1. Induced cell culture was centrifuged at 6,000 rpm for 20 min 
at 4 °C and the pellet was either frozen at -80 °C or re-suspended in 25 mL of lysis 
buffer (20 mM HEPES, 150 mM NaCl, 1 mM mercaptoethanol, 20 mM imidazole, 
pH 8) for sonication. 
2.3.5.2 Purification of GFP_BSP30B with IMAC and SEC 
The lysed suspension was centrifuged at 13,000 rpm for 20 min at 4 °C. The 
supernatant was filtered through 1 μm, 0.4 μm and 0.2 μm Minisart filters (Sartorius 
AG, Germany) consecutively before loading on the 5 ml HiTrapTM Chelating HP 
column. 
IMAC was performed as described in 2.1.1.3. Fractions containing GFP_BSP30b 
were then analysed by 12% SDS-PAGE gel. 
GFP_BSP30b was further purified with SEC as per 2.1.1.7 using SuperdexTM 200 
10/300 (S200 10/300) column (GE Healthcare, Sweden). Fractions containing 
GFP_BSP30b were then analysed by 12% SDS-PAGE gel and concentrated for 
further purpose. 
2.3.5.3 Concentration Measurement of GFP_BSP30b 
Since GFP_BSP30b has decent light absorbance at 280 nm, protein was quantified 
using a Nanodrop ND-2000 spectrophotometer (Nanodrop Technologies, USA). 




theoretical molar extinction coefficient was calculated using the online ProtParam 
tool (https://web.expasy.org/protparam/). 
2.3.6 Fluorescent Microscopy of GFP_BSP30b Mixed with Olive 
Oil 
20 μL of olive oil was mixed with 500 μL of GFP_BSP30b at concentration of 2 
mg/ml. This mixture was vortexed for 2 mins and left at room temperature for 20 
mins for equilibration. 20 μL of this mixture was pipetted on a glass slide and then 
covered with a cover slip. The slide having the mixture was viewed by using a 
ZEISS AXIOSTAR (LLC, US) bench top microscope. Images were captured at 40 
x magnification with filter 1 (blue light) or filter 2 (green light) using a Nikon 
Coolpix 4500 camera (Tokyo, Japan). 
The mixture was further viewed under a fluorescent microscope at Waikato 
Biological Imaging Facility (the University of Waikato, New Zealand). Images 
were captured at 100 x magnification using a Leica BFP/GFP filter block and 
Olympus DP70 camera. 
2.3.7 Transmission Electron Microscopy (TEM) of Protein 
Samples 
Emulsion samples for negative stain electron microscopy were prepared as follows: 
5 µL of freshly prepared emulsions were applied to a 300 mesh copper EM grid 
(GCU300 ProSciTech, Australia) covered with carbon-film supported by plastic 
that had been previously rendered hydrophilic by glow discharge. After 90s, the 
emulsion sample was blotted from the edge of the drop with filter paper (Whatman 
No 1) and washed three times with filtered MQ H2O. The specimen was now stained 




The sample was then blotted again and air dried. Images were captured at 
magnification of 40,000 using either a Phillips CM12 or a FEI TecNai G2 electron 
microscope. Both electron microscopes were equipped with a LaB6 filament and 
operated at 120 kV. Images with scale bars of 0.2 µm, 0.5 µm and 1 µm were 
recorded at 52,000 x, 40,000 x, and 11,500 x magnification respectively. 
2.3.8 Binding Ability of GFP_BSP30b to Rumen Samples 
2.3.8.1 Rumen Fluid Collection and Sample Preparation 
Rumen fluid was collected from a fistulated cow at AgResearch (Palmerston North, 
New Zealand). After filtration through cheesecloth to remove large feed particles, 
the fluid was kept at 39 °C in a water bath with CO2 supplied. This filtered fluid 
will be used directly or separated into bacterial and protozoal fractions. 
2.3.8.2 Binding of GFP_BSP30b to Rumen Fluid 
Purified GFP_BSP30b protein was taken to Agresearch and serially diluted 1:100, 
1:104, and 1:106 with sterile MilliQ water before mixing with rumen fluid. The 
filtered rumen fluid was then mixed with GFP_BSP30b dilutions separately. 20 μL 
of each mixture was loaded on a slide and viewed under fluorescent microscope at 
AgResearch. Images were captured at 40 x or 100x magnification with blue light or 
bright field. 
2.3.8.3 Binding Assay of GFP_BSP30b to Rumen Bacterial Fraction or 
Protozoal Fraction 
To obtain the bacterial and protozoal fractions, rumen fluid was centrifuged at 300 
g for 5 min. The pellet, which contained the protozoa and some bacteria, was diluted 




mM Urea, and 58.4 mM NaCl) to the same volume as the supernatant. The 
supernatant, which then contained the bulk of the bacteria, was centrifuged at 
15,000 g for 15 min to pellet the bacteria. The bacteria pellet was then re-suspended 
with Saliva Buffer to the same volume as the supernatant. 
Serially diluted protein was mixed with protozoal or bacterial fractions at a ratio of 
1:1. 20 μL of each mixture was pipetted on a slide and viewed under fluorescent 
microscope. Images were captured at 100 x magnification with blue light or bright 





Chapter Three. Expression and Purification of 
BSP30b and its derivatives 
3.1 Introduction 
This chapter focuses on the expression and purification of BSP30b in the pTriex-4 
Ek/LIC vector, BSP30b_F52M_F106M with or without SeMet incorporation in the 
pProEx Htb plasmid, and MBP_BSP30b_F52M_F106M in the pMAL-c2X vector. 
pTriex-4 Ek/LIC containing BSP30b was kindly given by Tom Wheeler at 
AgResearch and the protein had been previously expressed in E. coli Origami 
(DE3) pLacI cells. This plasmid was later transformed into E. coli BL21 in the 
Arcus lab by Dr Judith Burrows and expression trials had been performed using LB 
media. During this study, only large scale expression has been conducted using both 
LB media and auto-induction media. 
My strategy was to take a synthesized BSP30b_F52M_F106M gene and ligate this 
into pProEx Htb for protein expressed in M9 minimal media. This would then allow 
the protein to be further expressed with SeMet incorporation. This protein would 
then be purified and crystallised for SAD experiments to solve the phase problem.  
A second strategy was to use MBP as a fusion protein to facilitate crystallization. 
A previous study has shown that SPLUNC1 was successfully crystallized as MBP-
SPLUNC1 fusion protein (Ning et al., 2014). Hence, 




All of the expressed proteins above were purified using ӒKTA BasicTM FPLC 
system. The purified proteins were subjected to crystallization trials for X-ray 
diffraction experiment. 
3.2 BSP30b Expression in Both LB and Auto-induction 
Media 
Cloning and small scale expression trials were previously conducted and optimized 
by Dr Judith Burrows in the Arcus lab. Protein expression cultures then were scaled 
up and BSP30b was expressed in E. coli BL21 cells as a 29.6 kDa recombinant 
protein fused to an N-terminal 6x histidine tag. Large scale expression was 
conducted with both LB media and auto-induction media. 
BSP30b was first purified with a 5 ml Ni Trap column on ӒKTA BasicTM and 
analysed by SDS-PAGE. Protein expressed in LB media has two small peaks (A 
and B) on chromatogram for 280 nm (Fig. 3.1a). SDS PAGE gel results indicated 
that most of the weak binding impurities were eluted between fractions A5 and A13 
(Fig. 3.1a), corresponding to peak A on the chromatogram. BSP30b was eluted 
between fractions B5 and C2, corresponding to peak B on chromatogram. 
BSP30b was expressed at a much higher levels in auto-induction media compared 
to LB media. Instead of having two small peaks, there was only one large peak 
shown on this chromatogram. SDS PAGE results suggested that BSP30b and 
impurities were eluted at the same time between B8 and C4, corresponding to peak 





Figure 3.1 IMAC purification and corresponding SDS-PAGE analysis of BSP30b. Chromatogram of UV 
absorbance profile and its corresponding fractions on SDS PAGE when BSP30b was expressed in LB (a) and 
auto-induction (b) media, respectively. Peaks on chromatograms and their corresponding protein bands on 
SDS PAGE gel were highlighted. 
 
The protein was further purified with a size exclusion chromatography column and 
analysed with SDS PAGE. Protein expressed in LB media had three peaks on the 
chromatogram of SEC (Fig. 3.2a). Peak A corresponds to high molecular weight 
impurities on SDS PAGE. BSP30b was eluted during peak B and peak C. However, 
only BSP30b from peak C was concentrated for crystallization trials as fractions of 
peak B also contained other protein impurities as shown on SDS PAGE (Fig. 3.2a), 
which may prevent the crystallization of BSP30b.  
Protein expressed in auto-induction media had two peaks on the chromatogram of 
SEC. SDS PAGE results suggested that BSP30b was eluted during peak A and peak 
B (Fig. 3.2b). Although there was more absorbance at 280 nm at peak A compared 




shown on SDS PAGE gel. Only BSP30b eluted at peak B was used for 
crystallization trials because of its higher purity compared to fractions of peak A. 
Both chromatograms of SEC and their corresponding SDS PAGE gels suggested 
that BSP30b was eluted during 50 – 65 mL elution buffer, within the size range of 
17 – 44 kDa, suggesting it is in a monomeric state (29.6 kDa). 
 
Figure 3.2. SEC of BSP30b and corresponding SDS PAGE analysis. The UV absorbance profile during elution 
and its corresponding fractions on SDS PAGE when BSP30b was expressed in LB (a) or auto-induction (b) 
media. Peaks on chromatograms and their corresponding protein bands on SDS PAGE gel were highlighted. 
 
3.3 BSP30b_F52M_F106M Was Successfully Cloned into 
pProEx Htb 
3.3.1 Determination of the Mutation Sites of BSP30b 
The two methionine mutation sites were selected carefully as this was crucial so as 
not to disrupt the structure and to ensure crystallization. SeMet derivatives could 




Since only two protein structures (SPLUNC1 and latherin) of the PLUNC family 
were available, the mutation sites were determined according to the structural 
alignment of SPLUNC1 and latherin, combined with the sequence alignment of 
BSP30b, SPLUNC1, and Latherin (Fig. 3.3 and 3.4).  
The mutation sites were selected based on three criteria. The first being that the 
amino acid is hydrophobic and conserved in latherin and SPLUNC1 but varied in 
BSP30b. The second being that the side chain of the amino acid is buried in the 
structure so that the introduced methionine would be ordered and provide an 
anomalous signal. The third criteria is that the amino acids are separated spatially 
to provide a phasing signal across the molecule. After inspection of both the 
structural alignment and the sequence alignment, two phenylalanine residues 
(residues 52 and 106) for BSP30b were chosen for mutagenesis. 
 
Figure 3.3 Sequence alignment of BSP30b, latherin, and SPLUNC1 using Geneious 7.1.5 (Biomatters Ltd, 






Figure 3.4 Structural alignment of SPLUNC1 and latherin using PyMOL (Delano Scientific). SPLUNC1 and 
latherin was coloured in light pink and light blue, respectively. The two corresponding mutation sties were 
shown as sticks, which were coloured in red and magenta, separately.  
 
3.3.2 Cloning of BSP30b_F52M_F106M into pProEx Htb  
A commercially synthesized gene encoding BSP30b_F52M_F106M in the plasmid 
pMA-T was first transformed into E. coli DH5α cells for plasmid enrichment. The 
transformation success was confirmed by colony PCR (Fig. 3.5a). 
BSP30b_F52M_F106M was then digested out from plasmid pMA-T, and ligated 
into pProEx Htb. This ligated reaction was transformed into E. coli BL21 for protein 
expression. The success of transformation was confirmed by colony PCR and the 
predicted 777 bp product was correctly shown on an agarose gel after 
electrophoresis of the PCR amplicon (Fig. 3.5b). Analysis of the Sanger Sequencing 
result of this PCR product with Geneious indicated that the BSP30b mutant gene 
was successfully inserted into pProEx Htb and no unwanted mutations were 





Figure 3.5 Colony PCR results. a, colony PCR using gene specific primers had an amplicon ~ 723 bp. b, colony 
PCR using primers flanking BSP30b_F52M_106M had an amplicon ~ 777 bp. 
 
3.4 BSP30b_F52M_F106M Expressed in Minimal Media 
at Low Level 
BSP30b_F52M_F106M was first expressed in minimal media without SeMet 
incorporation to examine its expression level. It was expressed as a 27.8 kDa 
recombinant protein fused to a N-terminal 6 X histidine tag. Large scale expressed 
BSP30b_F52M_F106M was first purified using IMAC. The chromatogram and 
corresponding SDS-PAGE gel results indicated that most of 
BSP30b_F52M_F106M was eluted between B14 and C5, corresponding to peak B 
on chromatogram (Fig. 3.6). It was noticed that the BSP30b mutant was expressed 
at a much lower level compared to native BSP30b, suggested by those light bands 






Figure 3.6 IMAC purification and corresponding SDS PAGE analysis of BSP30b_F52M_F106M. The 
chromatogram depicts the UV absorbance during elution and the corresponding SDS PAGE gel depicts the 
fractions containing BSP30b_F52M_F106M. Peaks on chromatograms and their corresponding protein bands 
on SDS PAGE gel were highlighted. 
 
BSP30b_F52M_F106M was further purified with SEC to remove impurities. The 
chromatogram and corresponding SDS PAGE results suggested that 
BSP30b_F52M_F106M was eluted off the column as a single peak between 
fractions A8 and B3 (Fig. 3.7). Those fractions corresponded to 50 – 55 mL of 
elution buffer, within the size range of 17 – 44 kDa, suggesting it is in a monomeric 
state (27.8 kDa). 
Based on these results, the BSP30b double mutant was further expressed and 





Figure 3.7 SEC purification and corresponding SDS PAGE analysis of BSP30b_F52M_F106M. The 
chromatogram depicts the UV absorbance during elution and the corresponding SDS PAGE gel depicts the 
fractions containing BSP30b_F52M_F106M. Peaks on chromatograms and their corresponding protein bands 
on SDS PAGE gel were highlighted. 
 
3.5 Expression and Purification of SeMet Incorporated 
BSP30b_F52M_F106M 
The BSP30b double mutant was further expressed as selenomethionine (SeMet) 
incorporated protein in order to solve the phase problem. The expressed protein was 
first purified with IMAC. There was only a single peak on the chromatogram but 
this peak represented a mixture of different proteins including SeMet incorporated 
BSP30b mutant as shown on SDS PAGE gel (Fig 3.8a). This protein mixture was 
mainly composed of two different proteins, which have similar molecular weight. 
Both proteins were expressed at a relatively low levels and it was hard to determine 
which band represented the BSP30b double mutant SeMet derivative. Moreover, 
separation of these two proteins by SEC was impractical because of their similar 
size. 
In order to solve this problem, an anion exchange chromatography step was inserted 
before SEC in order to separate these two proteins based on their charge. BSP30b 




chromatogram and corresponding SDS PAGE results showed that these two 
proteins were well separated after anion exchange chromatography (Fig. 3.8b). The 
unknown protein was eluted first between fractions B12 and C2, shown as peak A 
on chromatogram and section A on SDS PAGE gel. While BSP30b double mutant 
SeMet derivative was eluted later, between fractions C14 and D6. 
 
Figure 3.8 Purification of BSP30b_F52M_F106M SeMet derivative. a, chromatogram and corresponding SDS 
PAGE result of IMAC. b, chromatogram and corresponding SDS PAGE result of anion exchange 
chromatography. c, chromatogram and corresponding SDS PAGE result of SEC. Peaks on chromatograms 
and their corresponding protein bands on SDS PAGE gel were highlighted. 
 
Size Exclusion Chromatography was still used for further purification despite the 




mutant from other protein contaminants at low concentration; another reason was 
to remove the excess salt from anion exchange chromatography, which may inhibit 
the crystallization of SeMet incorporated BSP30b mutant. The chromatogram and 
corresponding SDS PAGE results suggested that BSP30b double mutant SeMet 
derivative was eluted between fractions A13 and B5 (peak B in figure 3.8c). Protein 
from these fractions was concentrated and used for crystallization trials later. 
 
3.6 Generation of MBP fused BSP30b_F52M_F106M 
MBP fused BSP30b mutant was constructed due to the fact that the structure of 
SPLUNC1 (also a PLUNC protein) was solved with a MBP tag (Ning et al., 2014), 
which was supposed to improve the stability of SPLUNC1 and also help to solve 
the phase problem using MR (molecular replacement).  
The BSP30b_F52M_F106M gene was amplified by PCR from the pMA-T_BSP30b 
mutant plasmid and cloned into the cytoplasmic expression vector pMAL-c2X using 
the BamHI/PstI restriction sites, positioning an MBP tag at the N-terminus of the 
protein. The insertion of BSP30b double mutant was confirmed by colony PCR 
amplification, resulting in an 890 bp band as expected on the agarose gel after 






Figure 3.9 Colony PCR results. PCR using primers flanking BSP30b_F52M_F106M, resulting in an ~ 890 bp 
band on agarose gel after electrophoresis. 
 
3.7 Expression of BSP30b Mutant with MBP Tag 
Improves Protein Yield 
MBP fused BSP30b mutant was expressed in LB media as a 75 kDa protein. The 
protein was first purified with amylose resin chromatography. The chromatogram 
and corresponding SDS PAGE gel results suggested that the protein was tightly 
bound to the column and was well eluted between fractions A7 and A12 (Fig. 
3.10a). Noticeably, compared to the expression level of BSP30b double mutant in 
E. coli BL21 cells, there was a large improvement on the yield of the expressed 
protein, indicated by the significant UV absorbance on chromatogram and thick 
bands on SDS PAGE gel. It is noted that a few protein impurities were also eluted 
at the same time as MBP_BSP30b_F52M_F106M. 
The protein was further purified with SEC. The chromatogram and corresponding 




two peaks (peak B and C, Fig. 3.10b). Protein eluted during peak B had a molecular 
weight similar to the model protein IgG (molecular weight of 158 kDa), indicating 
the eluted MBP_BSP30b_F52M_F106M was a dimer. Protein eluted during peak 
C had a similar elution profile to the model protein albumin, which has a molecular 
weight of 66 kDa, suggesting the protein is a monomer from this peak. The dimer 
was about two times the quantity of the monomer, indicated from their UV280 
absorbance and SDS PAGE gel results. Both monomeric and dimeric proteins were 
concentrated separately for crystallization trials. 
 
Figure 3.10 Purification of MBP_BSP30b mutant. a, chromatogram and corresponding SDS PAGE result of 
IMAC. b, chromatogram and corresponding SDS PAGE result of SEC. Peaks on chromatograms and their 






Native BSP30b was successfully expressed at high level in E. coli BL21 cells using 
both LB and auto-induction media. Unexpectedly, the expression level was 
dramatically increased in auto-induction media compared to its expression in LB 
media. Proteins expressed in both media were successfully purified using IMAC 
and SEC. Analysis of the SEC chromatogram suggested that BSP30b was in a 
monomeric state. 
Although BSP30b was well expressed in both media indicated by their 
corresponding SDS PAGE gel results, only small peaks were shown on its 
chromatograms during purifications. This is because BSP30b has no tryptophan 
amino acids, and hence it has poor UV light absorbance at 280 nm. It was noticed 
that there was only one single peak with decent UV absorbance in the 
chromatogram of IMAC of auto-induction expressed BSP30b; however, a few non-
BSP30b proteins were also purified together with BSP30b, which may contribute 
to most of the light absorbance at 280 nm. This could be true as, after SEC, the light 
absorbance of those non-BSP30b proteins is much higher compared to that of 
BSP30b, although they were at much lower quantities. 
As BSP30b doesn’t contain any methionine, two phenylalanine to methionine 
mutations (F52M, F106M) were introduced into BSP30b for phasing. The 
synthesized gene coding for BSP30b_F52M_F106M was successfully inserted into 
protein expression vector pProEx Htb, downstream of the trc promoter. 
BSP30b_F52M_F106M was first expressed in E. coli using M9 minimal media. 
However, it was expressed at much lower level compared to native BSP30b. Protein 




on the SDS PAGE gel, they did not trigger special attention as those two proteins 
were eluted separately during IMAC and native BSP30b was well eluted as a single 
band on SDS PAGE gel when using SEC. However, when BSP30b_F52M_F106M 
was expressed as SeMet incorporated protein in E. coli using M9 minimal media, 
these two bands were overlapped on SDS PAGE gel after IMAC. Because of the 
overlapping of these two proteins and their similar size, further purification with 
SEC was impractical. Another question from this situation was which band on SDS 
PAGE represents the SeMet incorporated protein. Based on the fact that BSP30b 
has a relatively low pI of 4.4, an anion exchange chromatography step was inserted 
before SEC for protein separation. These two proteins were well separated after 
anion exchange chromatography. The unknown protein was eluted out first and 
BSP30b_F52M_F106M SeMet derivative was salted out later because of its tight 
binding to the column. The SeMet incorporated BSP30b mutant was further 
purified with SEC to remove extra salt, which may inhibit the crystallization of the 
protein. 
The gene coding BSP30b_F52M_F106M was also cloned into pMAL-c2X, which 
will leave an MBP tag at the N terminus of BSP30b mutant. There have been a 
growing number of proteins which have been crystalized as MBP fusion proteins. 
Indeed, about 100 MBP fusion protein structures has been deposited in the Protein 
Data Bank (PDB) since 2003 (Waugh, 2016). The MBP tag was believed to 
improve the expression, solubility, stability, or crystallization of the target protein. 
Moreover, the initial phases can be simply obtained by molecular replacement using 
MBP as the reference model. Another advantage for this study is that the quantity 
of the expressed MBP fusion protein can be easily examined using Nanodrop 




In this study, the expression level of BSP30b_F52M_F106M was increased 
dramatically after fused to MBP. The MBP fusion protein was successfully eluted 
using MBP Trap column at first, and then purified by SEC. The SEC purified 
MBP_BSP30b_F52M_F106M has both monomeric and dimeric states. Both 
monomer and dimer of MBP-BSP30b_F52M_F106M were concentrated separately 





Chapter Four. The Three-dimensional 
Structure of BSP30b 
4.1 Introduction 
One of the central objectives of this PhD research was to determine the three 
dimensional structure of BSP30b as a means of narrowing down its possible 
biological function. In order to solve the structure of BSP30b, the purified BSP30b, 
BSP30b_F52M_F106M SeMet derivative, and MBP-BSP30b_F52M_F106M were 
all screened using crystallization trials and the resulting crystals were then subjected 
to X-ray diffraction experiments.  
Previously, an X-ray diffraction dataset of native BSP30b was collected at 2.5 Å 
from a colleague of the Arcus group. In the present study, in-depth optimization of 
the previous crystallization conditions were performed to yield crystals with 
improved diffraction so the structure of BSP30b might be solved by sulfur-SAD or 
direct methods. To solve the phase problem, the traditional MIR (multiple 
isomorphous replacement) approach was also tested by soaking BSP30b crystals in 
heavy atom solutions. 
Crystallization trials were also conducted for SeMet incorporated 
BSP30b_F52M_F106M in order to solve the structure of BSP30b using the 
anomalous signal of selenium. 
The MBP-BSP30b_F52M_F106M fusion protein was also set up for crystallization 
trials so that the structure of BSP30b could be solved by molecular replacement, 




4.2 Crystallization of BSP30b 
4.2.1 Robotic Crystallization Screens of BSP30b 
Size exclusion chromatography purified BSP30b was subjected to robotic 
crystallisation screens (96 x 4 different conditions) at concentration of 10 mg/ml 
and needle shaped crystals were observed in seven conditions (Appendix A5). Fine 
screens based on these condidtions were then trialed using the hanging drop method, 
however this resulted in limited crystal development.  
 
Figure 4.1 Representation of needle shaped crystals from robotic screen. 
 
4.2.2 Fine Screen of BSP30b 
Previously determined crystallization conditions from the Arcus lab were also set 
up for fine screens with BSP30b at a concentration of 10 mg/ml. After repeating the 
fine screen a few times, condition “B3” (0.1 M HEPES pH 7.5, 0.2 M CaCl2, 9% 
w/v PEG 3350, 5% v/v IPA) repeatedly produced needle-shaped or plate-shaped 
crystal “hits” (Fig. 4.2). Crystals were taken to the Australian Synchrotron for X-
ray diffraction. Those needle-shaped crystals generally had poor diffraction at ~8 Å 




only diffracted to ~ 6 Å resolution. Extensive optimisation of this crystalization 
condition were carried out to obtain crystals with better diffraction quality. 
 
Figure 4.2 Crystals of BSP30b generated from condition “B3”. a, needle shaped crystals grown in condition 
“B3” with poor diffraction. b, thin plate shaped crystals grown in condition “B3” with diffraction ~ 6 Å.  
 
4.2.3 Optimisation of Condition “B3” 
4.2.3.1 Additive Screen 
The Hampton additive screen was set up with BSP30b at 10 mg/ml using condition 
“B3” as its basis. Among the 96 conditions, 55 conditions had crystals grown after 
19 days, and 20 of them resulted in thick-rod or thick-plate shaped crystals. Fine 
screens of 15 conditions were performed and protein crystals were grown in six 
conditions after ~ 2 weeks (Fig. 4.3). Thick rods were grown in fine screens with 
the “additives” glucose monohydrate or galactose. Single small rods were grown in 
fine screens with the “additives” glycine or sodium iodide. Both fine and robotic 
additive screens with manganese chloride tetrahydrate had irregular shaped crystals. 




Crystals from those conditions were tested on our home source X-ray beam and at 
the Australian Synchrotron: the thick rod-shaped crystals had relatively better 
diffraction to ~ 5 Å resolution. 
 
Figure 4.3 Crystals grown in 6 conditions of additive screen in both robotic and fine screen. Thick rods were 
grown in fine screens with “additives” glucose monohydrate or galactose. Single small rods were grown in 
fine screens with “additives” glycine or sodium iodide. Irregular shaped crystals were grown with additive 





4.2.3.2 Trypsin digestion of BSP30b 
Pre-incubation of BSP30b at 10 mg/ml with trypsin was also performed for 
crystallization. The pre-incubation time was optimised by running an SDS PAGE 
gel with mixtures of trypsin and BSP30b at a ratio of 1:100 at different time 
intervals (Fig. 4.4). Nearly all BSP30b was digested into a single band (~32 kDa) 
after pre-incubation of 1 minute. After incubation of 1 hour, most of the BSP30b 
was digested into a smaller bands (~27 kDa). 
 
Figure 4.4 Trypsin digestion assay of BSP30b. BSP30b was digested during different time intervals and then 
electrophoresed on SDS PAGE gel. Different band patterns were seen on the gel. BSP30b without digestion 
was used as control. 
 
Fine screens of BSP30b pre-incubated with trypsin for 1 min was performed and 
tiny crystals appeared in the drop after a week (Fig. 4.5). Those crystals were taken 






Figure 4.5 Crystals of trypsin digested protein having a poor diffraction. Tiny crystals with uneven surface 
were grown after trypsin digestion. Only a few spots appeared on the detector after shooting with X-ray, 
suggesting its poor diffraction. 
 
4.2.3.3 Silver bullet screen of BSP30b 
The Hampton silver bullet screen was also trialled with BSP30b at 10 mg/ml using 
condition “B3”. 13 conditions had better needle-shaped crystals formed after ~2 
weeks (Fig. 4.6). However, the crystals from these fine screens had no or very poor 
diffraction at the Australian Synchrotron. 
 
Figure 4.6 Silver bullet screen. Needle (a) or thin-rod (b) shaped crystals were formed during silver bullet 





4.2.3.4 Seeding of BSP30b 
4.2.3.4.1 Crystals Grown in Streak Seeding Dissolved Again 
Streaking seeding yielded some chunky and thick rod-shaped crystals along the 
streak as well as some thin needles within the drop after 2 days. Unfortunately, 
those crystals dissolved after 2 weeks (Fig. 4.7). 
 
Figure 4.7 Streak seeding. Chunky and fatty rod-shaped crystals (a) were produced with streak seeding. 
However, those crystals were dissolved later (b) before shooting by X-ray. 
 
4.2.3.4.2 Batch Seeding Yielded Crystals with Improved Diffraction 
Crystallization using batch seeding resulted in more success. Most of the batch 
seeding drops had crystal “hits” in three different morphologies after 5 days (Fig. 
4.8). All of the drops had needle-like and plate-shaped crystals with medium 
thickness. Several drops also had crystals with a third boulder-like morphology. 
Those plate-shaped and boulder-shaped crystals were taken to the Australian 
Synchrotron for diffraction. Those boulder-shaped crystals had poor diffraction ~ 5 
Å resolution. Those plate-shaped crystals had relatively better diffraction ~ 3 Å 







Figure 4.8 Batch seeding of BSP30b. Different morphological crystals were grown in batch seeding. The 
boulder shaped ones had diffractions ~ 5 Å. Plate shaped crystals had diffractions ~ 3 Å. 
 
4.2.3.5 Gel Shift Assay and Heavy Metal Soak of BSP30b 
Native gel shift assays are a simple method for searching for heavy metal 
derivatives. Eight heavy metal compounds were chosen to mix with BSP30b 
separately followed by running native PAGE. Obvious band shifts were observed 
when BSP30b was mixed with KAu(CN)2, K2PtCl4, and K2PtCl6, respectively. For 





Figure 4.9 Native gel shift assay results. All of the heavy atom compounds used at a final concentration of 2mM. 
BSP30b itself without heavy atom compound was used as control. Band shifting was seen with heavy atom 
compounds KAu(CN)2, K2PtCl4, and K2PtCl6, respectively. 
 
KAu(CN)2 soaked crystals had a pink/red colour, indicating the potential binding 
of heavy atoms to the crystals (Fig. 4.10b). Those crystals diffracted to ~ 3 Å 
resolution at the Australian Synchrotron; however, the anomalous signal was too 
weak after scaling in CCP4. This could because there was only transient binding 
between the gold ion and BSP30b, and hence no obvious anomalous signal was 
observed. 
After soaking in K2PtCl4, there was no colour change for the crystals (Fig. 4.10a). 
Crystals were taken to Australian Synchrotron and most of them diffracted to ~ 5 Å 





Figure 4.10 Heavy metal soaked crystals and their diffraction. a, K2PtCl4 soaked BSP30b crystal with 
diffraction of 5 Å. b, crystal soaked in KAu(CN)2 had a pink/red colour and diffracted to 3.06 Å. 
 
4.3 Crystallization of BSP30b_F52M_F106M SeMet 
Derivative 
4.3.1 Robotic Screen 
Because of the low expression of SeMet-incorporated BSP30b double mutant, only 
crystal screens and index screens were set up for crystallization at 8 mg/ml. After 
10 days, tiny crystals appeared in two conditions. Hanging drop fine screens of 




4.3.2 Fine screen 
BSP30b double mutant SeMet derivative at 10 mg/ml was set up for fine screens 
with the old 24 conditions (Table 4.1). The conditions comprise a combination of 
HEPES (pH 7.5), CaCl2, PEG 3350, and isoproponal at various concentrations. 
Those conditons have been proven to produce crystals using native BSP30b. Here, 
they were tested for crystallization of BSP30b double mutant SeMet derivative. 
Rod/cluster-shaped crystals appeared in conditions B3 – B6, C3 – C6 and D4 – D6 
after 2 weeks (Fig. 4.11). Those crystals were broken into single crystals, which 
were then frozen and taken to the Australian Synchrotron for X-ray diffraction. 
Most of the crystals had good diffraction ranging from 1.9 Å to 2.5 Å resolution.  
 
Figure 4.11 Rod-cluster shaped crystals of BSP30b mutant SeMet derivative with diffraction of 1.9 Å. Rod-
cluster shaped crystals was grown after 2 weeks. Crystals were broken into single ones with the best diffraction 





Table 4.1 The previously determined 24 conditons 






















A1 A2 A3 A4 A5 A6 
HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 
CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCL2 0.2 CaCL2 0.2 
PEG 3350 5 PEG 3350 7 PEG 3350 9 PEG 3350 11 PEG 3350 13 PEG 3350 15 
IPA 0 IPA 0 IPA 0 IPA 0 IPA 0 IPA 0 
MQ H2O   MQ H2O   MQ H2O   MQ H2O   MQ H2O   MQ H2O   
B1 B2 B3 B4 B5 B6 
HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 
CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCL2 0.2 CaCL2 0.2 
PEG 3350 5 PEG 3350 7 PEG 3350 9 PEG 3350 11 PEG 3350 13 PEG 3350 15 
IPA 5 IPA 5 IPA 5 IPA 5 IPA 5 IPA 5 
MQ H2O   MQ H2O   MQ H2O   MQ H2O   MQ H2O   MQ H2O   
C1 C2 C3 C4 C5 C6 
HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 
CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCL2 0.2 CaCL2 0.2 
PEG 3350 5 PEG 3350 7 PEG 3350 9 PEG 3350 11 PEG 3350 13 PEG 3350 15 
IPA 10 IPA 10 IPA 10 IPA 10 IPA 10 IPA 10 
MQ H2O   MQ H2O   MQ H2O   MQ H2O   MQ H2O   MQ H2O   
D1 D2 D3 D4 D5 D6 
HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 HEPES 0.1 
CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCl2 0.2 CaCL2 0.2 CaCL2 0.2 
PEG 3350 5 PEG 3350 7 PEG 3350 9 PEG 3350 11 PEG 3350 13 PEG 3350 15 
IPA 15 IPA 15 IPA 15 IPA 15 IPA 15 IPA 15 





4.3.3 Initial Data Processing for BSP30b Double Mutant SeMet 
Derivative 
Data was collected to 1.9 Å with 98.9% completeness at a wavelength of 0.9537 Å. 
The dataset was indexed as the C2 space group and integrated using iMosflm 
(Leslie & Powell, 2007). Matthews_Coeff analysis indicated that the asymmetric 
unit contains two BSP30b molecules and the solvent content of the unit cell is 42.7% 
(Table 4.2). The data were scaled with a resolution limit of 2 Å to reach appropriate 
Rmerge and CC (1/2) values (see table 4.5). Significant anomalous signal was 
detected after scaling. 
 
Table 4.2 Matthew Coeff results of BSP30b mutant 
 
 
4.3.4 Structure Solution and Refinement 
Phasing was achieved using the single-wavelength anomalous diffraction (SAD) 
technique to solve the structure of BSP30b. Six initial selenium sites were identified 
by running AutoSol in Phenix (Table 4.3). Phases from these six sites gave a low 
figure of merit (FOM) of 0.273. Nonetheless, using these phases as a starting point, 




Table 4.3 AutoSol results. a, results from heavy atom search and phasing. b, results from model building 
 
 
The structure of BSP30b was further built with AutoBuild in Phenix. The protein 
sequence data and four files created by AutoSol (containing experimental data, 
initial map, starting model and heavy-atom sites, respectively) were used for this 
purpose. The resulting model from AutoBuild gave 337 protein residues and 251 
water molecules (Table 4.4). 
Table 4.4 AutoBuild results 
 
 
The structure of BSP30b from AutoBuild was then refined with phenix.refine in 
Phenix. Subsequent cycles of manual model building using COOT 0.7 and 
refinement using phenix.refine were performed until no improvement in Rfree values 





Table 4.5 Data collection and refinement statistics 
Property Value 
Wavelength 0.9537 Å 
Space group C121 
Cell constants 
a, b, c, α, β, ƴ 
81.65Å     59.57Å     89.94Å 
90.00°      106.25°    90.00°  
Resolution (Å) 47.43 – 2.00 (2.11 – 2.00) 
Rmerge 0.100 (0.622) 
CC (1/2) 0.998 (0.922) 
Completeness (%) 99.9 (100) 
Redundancy 7.2 (7.3) 
No. of observations 201779 (29708) 
No. of unique reflections  28136 (4080) 
Mean I/σ(I) 11.8 (3.5) 
Anomalous completeness (%) 98.5 (98.1) 
Anomalous multiplicity 3.7(3.8) 
DelAnom correlation between half sets 0.130 (0.020) 
Rwork 0.2051 
Rfree 0.2514 
Total number of atoms 3064 
Average B, all atoms (Å2) 36.0 
Ramachandran favoured (outliers) 97.05% (0.00%) 
Rotamer outliers 0.00% 





4.3.5 Structural analysis 
Crystals of a double Phe-to-Met mutant of BSP30b diffracted to 2.0 Å resolution 
with a space group of C2 and unit cell dimensions and angles: a = 81.65Å, b = 
59.57Å, c = 89.94Å, α = ƴ = 90°, β = 106.25°. The structure was determined using 
SeMet incorporated protein and Single-wavelength anomalous dispersion (SAD) 
methods. 
BSP30b crystallized as two molecules in ASU (asymmetry unit) shown in figure 
4.12a. Each molecule of BSP30b consists of 7 α helices and 6 β sheets as well as 
connecting turns and loops which envelope a hydrophobic channel conserved 
within the TULIP superfamily (Fig. 4.12b). It is clear that the first 39 amino acids 
of the recombinated BSP30b are disordered. Of which, 29 amino acids come from 
the vector while the remaining 10 amino acids come from BSP30b. The structure 
of BSP30b begins with a helix (α1, residues 40-48), followed by a short helix (α2, 
residues 50-53). Two antiparallel α helices (α3, residues 55-69; α4 residues 81-100) 
follow and noticeably, no continuous density was found to connect these two 
helices in either the initial electron density map or the final refined model. Hence, 
residues 74-79 are missing from the model. This is followed by antiparallel β 
strands from β1 to β6 (β1 residues 103-106; β2 residues 114-117; β3 residues 122-
137; β4 140-158; β5 167-169; β6 179-185) and these form a long highly twisted β-
strand. There is a short α helix (α5 residues 176-178) between β5 and β6. A long 
bent α helix (α6 residues 193-224) follows β6 and the structure ends with a unique 
C-terminal helix (α7 residues 227-235).  
The hydrophobic channel of BSP30b (well-conserved across the TULIP 




calculated internal cavity using PyMOL (DeLano Scientific) suggests that its 
potential opening is at the C-terminal end along the long axis of the structure (Fig 
4.12d). The length of the internal cavity extends ~ 22.6 Å. We expect that the 
flexible loop between helices α3 and α4 at the opening region will move away upon 
ligand binding. BSP30b also has a conserved disulfide bridge (of the PLUNC 
family) formed between cysteine 172 and 225 and joining the long-curved helix α6 
and the loop region between helix α5 and sheet β5. This disulfide bond has been 
proposed to maintain the stability of the entire structure of SPLUNC1 (Ning et al., 
2014). Since this disulphide bond of BSP30b is located at the same postion as in 
SPLUNC1, we believe that this disulphide bond also stabilises the whole structure 
of BSP30b.. Moreover, two metal ion sites are predicted from the electron density 
map, and both have regular octahedral geometry. The most likely metal ion is 






Figure 4.12 Overall structure of BSP30b. 1a, asymmetric unit of the BSP30b crystal, composed of two copies 
of the BSP30b molecule. 1b, the tertiary structure of apo-BSP30b, coloured in rainbow mode ranging from 
blue (N terminus) to red (C terminus). 1c, topology diagram of BSP30b. All seven α helices are represented by 
red cylinders; six β strands by yellow arrows; green lines represent the loops and turns within the structure. 
1d, representation of the internal cavity, calculated using PyMOL (Delano Scientific). 
 
4.3.6 Comparisons between BSP30b and SPLUNC1 Structures 
The BSP30b structure was compared with structures in PDB using the Dali server. 
From the Dali alignment, SPLUNC1 (Fig. 4.13a, PDB code 5I7K) from human has 
the closest structure to BSP30b, with a Z score of 10.5 and a root mean squared 
deviation (RMSD) for Cα of 3.8 Å (total of 204 residues included). Both proteins 
are members of the PLUNC group and have a tubular structure with the conserved 
hydrophobic channel. The conserved disulfide bond is also conserved between the 
two structures (Fig. 4.13a and b) and thought to maintain structural stability. 
There are two significant differences between the two structures. The first 




coloured in cyan) in BSP30b. This disulfide bond, formed between Cys72 and 
Cys229, connects the flexible loop just after helix α3 to the C-terminal helix α7. 
Intriguingly, electron density signifying this bond is only clear in one molecule in 
the asymmetric unit and is practically missing in the other molecule. This may 
indicate that this second disulfide bond is partially reduced.  
The second obvious difference is that the N-terminal and C-terminal ends of 
SPLUNC1 are located at the same place on the long axis; whilst both ends of 
BSP30b are located at the opposite site of the long axis (Fig. 4.13c). In BSP30b, its 
N-terminal consists of 4 helices (α1-α4) whilst there are only two helices (α1 and 
α2) present in SPLUNC1. Helix α4 of BSP30b runs roughly parallel to α1/α2 of 
SPLUNC1, while helices α1-α3 of BSP30b run antiparallel to α1/α2 of SPLUNC1. 
As a consequence, the respective N-terminus and C-terminus of both proteins are 
located either on the same (SPLUNC1) or opposite (BSP30b) sides. This structural 
difference seems to be critical for their ligand binding. Helices α1 and α2 of 
SPLUNC1 are V-shaped with helix α1 blocking the ligand access to the cavity, and 
it is anticipated that helix α1 will move away to “open up” the binding site upon 
ligand binding. For BSP30b, its helix α4 runs straight and leaves the cavity open. 
This different topology of the N-terminal part of BSP30b seems to be responsible 
for making the cavity accessible to ligand. 
 
The surface properties of BSP30b and SPLUNC1 are similar, containing negatively 
charged regions at their potential substrate binding sites (Fig4.14 c and d). This is 
different to BPI, whose substrate binding site is positively charged and it functions 




SPLUNC1 has been proposed to be a lipid binding protein based on its ligand 
binding site charge and in vitro assay, we believe BSP30b could also be a lipid 
binding protein because its ligand binding site has similar electrostatic potential as 
SPLUNC1, although their binding sites are formed differently. 
 
 
Figure 4.13 Structural comparison of BSP30b with hSPLUNC1. 2a, the structure of hSPLUNC1, with its 
disulfide bond shown in magenta. 2b, the structure of BSP30b. The universal disulfide bond is shown in 
magenta and its unique disulfide bond is shown is cyan. 2c, structural alignment of BSP30b to hSPLUNC1 
using PyMOL. BSP30b is shown in cyan and hSPLUNC1 is shown in green. Their structural differences are 
marked with different colours. For BSP30b, helices α1, α2, α3 is in hotpink and helix α7 is in red. For 






Figure 4.14 Comparison of the potential ligand binding sites of BSP30b and hSPLUNC1. The potential ligand 
binding sites were highlighted using dashed circles in each figure. a, cartoon representation of BSP30b. b, 
cartoon representation of hSPLUNC1. The electrostatic potential of BSP30b (c) and hSPLUNC1 (d) were 
depicted. Colours indicate the surface electrostatic potential: blue = positive (or above 0.1 Volt), white = neutral 
and red = negative (or below 0.1 Volt). 
 
4.3.7 Structural comparison of BSP30b to TULIP proteins with 
known structures 
The structure of BSP30b was also compared with the TULIP proteins whose 
structures have been deposited in the PDB. A sequence alignment of these proteins 
(13 in total) based on structure alignment was generated using PROMALS3D (Fig. 
4.15, http://prodata.swmed.edu/promals3d/promals3d.php). Generally, the 
secondary structures constituting the conserved tubular channel are well conserved 




clear that the C-terminal domains of BPI (1ewf), LBP (4m4d), and CETP (2obd) 
are well aligned but are different from E-syt 2 (4p42). This is because that the C-
terminal domain of E-syt 2 interacts with lipid bilayers, rather than lipid 









Figure 4.15 Sequence alignment of BSP30b with other 12 TULIP proteins based on structure alignment using 
PROMALS3D (http://prodata.swmed.edu/promals3d/promals3d.php). The corresponding proteins of these 
PDB codes in the figure are: BSP30b (5wd6), SPLUNC1 (4kgh), latherin (3zpm), BPI (1ewf), LBP (4m4d), Der p 7 
(3h4z), Der f 7 (3uv1), CETP (2obd), E-syt 2 (4p42), JHBP (3aos), Mmm1 (5yk6), Mdm (5gyd), Takeout 1 (3e8t). 
The conservative property of each aligned position is valued between 0 and 9, with 9 corresponding to highest 
conservation. The consensus_ss represents the conserved secondary structure, with h standing for alpha-helix 
(the corresponding amino acids are coloured in red) and e standing for beta-strand (the corresponding amino 
acids are coloured in blue). The amino acid having same property at each position is represented in 







4.3.8 Sequence Alignment of BSP30a and b 
A sequence alignment of BSP30a and b aiming to map the BSP30a sequence onto 
the structure of BSP30b was performed using PROMALS3D (Fig. 4.16). It is 
obvious that the two protein sequences are well aligned and are highly conserved 
(83% identity). However, some amino acid differences are also found in the 
alignment, which may affect the structure and function of BSP30a. The core 
differences were highlighted on the structure of BSP30b (Fig. 4.17). It is clear that 
the three hydrophobic amino acids (F85, L126, F188) on the surface of BSP30b are 
substituted to serine and proline. Since BSP30b is highly soluble and stable, it is 
hard to tell what the effects of these changes will be. It is also noticed that, one 
amino acid (F218) of BSP30b whose sidechain is buried in the hydrophobic channel 
is substituted to isoleucine in BSP30a. Compared to phenolalanine, isoleucine has 
a smaller sidechain, which might result in slightly larger internal space and different 





Figure 4.16 Sequence alignment of BSP30a and b using PROMALS3D. The predicted secondary structures of 
BSP30a are highlighted in blue (beta-strand) and red (alpha-helix) on amino acid sequence. The conserved 




Figure 4.17 The cartoon representation of BSP30b generated by using PYMOL. The major amino acid 
differences between BSP30a and b were highlighted in magenta, with sidechains shown as sticks. The 





4.4 BSP30b Structure Solved Using 
MBP_BSP30b_F52M_F106M 
4.4.1 Crystallization of MBP_BSP30b Mutant 
Purified MBP_BSP30b double mutant was subjected to fine screen at a 
concentration of 10 mg/ml using the previously determined 24 conditions for 
BSP30b. Single protein crystals were grown in conditions B3-B6, C3-C6, and D3-
D6 after 2 weeks (Fig. 4.18). Those crystals were taken to the Australian 
Synchrotron and most diffracted to ~ 2.5 Å. It was noticed that strong ice rings were 
seen during X-ray diffraction. This could be caused by a film layer formed over 
crystallization drops which may have attached to the surface of the protein crystals 
during looping. Nevertheless, data was collected for structure determination. 
 
 
Figure 4.18 Crystal of MBP_BSP30b_F52M_F106M with diffraction of 2.4 Å. Strong ice rings were shown 





4.4.2 Data Collection and Initial Analysis 
Data was collected to 2.4 Å resolution with 94.5% completeness at a wavelength of 
0.9537 Å. The dataset was indexed as C2 space group and integrated into an mtz 
file using iMosflm (Leslie & Powell, 2007). Initial Matthews Probability analysis 
indicated that the asymmetric unit has only one protein molecule and the solvent 
content is 16.5%, surprisingly low for a protein crystal (Table 4.6). 
Table 4.6 Matthews_Coeff results 
 
Initially, molecular replacement method was chosen to solve the structure of 
MBP_BSP30b mutant using the known structure of MBP on PDB (PDB code: 
4MBP or 1ANF). However, molecular replacement using phaser-MR failed to 
generate any solutions. During this time, the structure of BSP30b was solved using 
its SeMet derivative. Hence, molecular replacement was performed using BSP30b 
as the reference model. When looking back to the integrated dataset, it had the same 
space group as BSP30b itself and similar unit cell parameters. It is suspicious that 
only BSP30b_F52M_F106M was crystallized and MBP was removed during 
crystallization for some reason.  
After using BSP30b as a reference model and two molecules in the ASU, the 
structure was easily solved using phase_MR in Phenix. The resulting structure was 
first refined with phenix.refine in Phenix. Subsequent cycles of manual refinement 
using COOT 0.7 and phenix.refine were done until desirable Rfree and Rwork were 




Table 4.7 Data collection and refinement parameters 
Property Value 
Wavelength 0.9537 Å 
Space group C121 
Cell constants 
a, b, c, α, β, ƴ 
83.35Å     61.23Å     90.85Å 
90.00°      107.73°    90.00°  
Resolution (Å) 86.53 – 2.40 (2.53 – 2.40) 
Rmerge 0.177 (0.698) 
CC (1/2) 0.998 (0.929) 
Completeness (%) 94.5 (84.4) 
Redundancy 6.0 (6.2) 
No. of observations 97078 (13004) 
No. of unique reflections  16290 (2113) 
Mean I/σ(I) 5.5 (1.6) 
Rwork 0.2339 
Rfree 0.3062 
Average B, all atoms (Å2) 64.77 
Ramachandran favoured (outliers) 96.23% (0.54%) 
Rotamer outliers 0.00% 
Clash score 14.67 
 
4.4.3 Structural Analysis 
The structure of BSP30b was also solved using MBP tagged BSP30b, although 
MBP was removed during crystallization. Crystal diffracted to 2.4 Å with space 





BSP30b was crystallized as two molecules in the ASU as shown in Fig. 4.19. The 
structure also contains the well conserved hydrophobic channel. Although it was 
solved at a relative low resolution, it still maintained all the features as the one 
solved by its SeMet derivative. Both structures can be well aligned using PyMOL 
with a RMSD of 0.25 (149 to 149 atoms, fig. 4.20). It is interesting that both 
structures were solved from Valine38. The first 38 amino acids including the 6x 
His tag were missing in both structures, suggesting that this region should be very 
flexible and not well packed in the crystal. The potential ligand binding region was 
also well formed and the electron density for the loop between helices α3 and α4 
was also missing. Both structures ended with the C-terminal α helix and the last 13 
amino acid residues were missing in both structures.  
 
 
Figure 4.19 Cartoon representation of BSP30b structure. BSP30b was solved using 






Figure 4.20. Structural alignment of BSP30b solved by using BSP30b_F52M_F106M SeMet derivative (colored 
in cyan) and MBP-BSP30b_F52M_F106M (colored in yellow).  
 
4.5 Discussion 
4.5.1 Multiple Optimizations of BSP30b Crystallization 
Conditions Failed to Yield High Quality Crystals 
Multiple optimizations of crystallization conditions for BSP30b were conducted in 
this chapter aiming to produce protein crystals with high quality diffraction. Initial 
robot and fine screens only resulted in thin needles with very poor diffraction. 
Twenty four previously determined conditions were also used to set up fine screens 
and condition “B3” repeatedly had needle or plate shaped crystals which diffracted 
to around 6 Å resolution, insufficient to solve the structure. . 
Multiple optimizations of condition “B3” in this chapter improved the crystal 
quality of BSP30b. Additive Screens from Hampton Research contains 96 unique 
reagents, which can affect the solubility and crystallization of biological 




including the protein-protein interactions, or protein-solvent interacgions, as well 
as water structure. In this study, crystals were produced in 6 additive screen 
conditions, four of which produced better-quality crystals (“B3” + additive glucose 
monohydrate, galactose, glycine, or sodium iodide). Unfortunately, those crystals 
only marginally improved the diffraction to around 5 Å resolution.  
The Silver Bullets Screen is a library of small molecules which can promote 
stability, lattice formation, and crystallization. These small molecules are able to 
establish stabilizing, inter molecular, hydrogen bonding, hydrophobic and 
electrostatic interactions. Although the silver bullet screen yielded better-shaped 
needle crystals in this study, only poor diffraction was detected, suggesting that 
needle shaped crystals of BSP30b were not ideal for X-ray diffraction. 
In situ trypsin proteolysis is a well-developed method for improving protein 
crystallization, and aims to produce crystals after removing the protein residues in 
flexible regions. Dong et al. (Dong et al., 2007) reported that, after in situ 
proteolysis, 10 of 69 proteins which resisted structure determination were 
crystallized and their structures determined (14.5% success rate). Later research 
expanded to over 270 proteins that had failed in the past to produce crystals suitable 
for structure determination revealed that 34 yielded deposited crystal structures 
with an 12.6% success rate (Wernimont & Edwards, 2009). However, in this study, 
although the flexible regions were trimmed after in situ proteolysis, only tiny 
crystals were produced with uneven surface which had very poor diffraction.  
Seeding is also a well-developed method for optimization, which involves adding 
homogeneous or heterogeneous crystals to a crystallising solution to nucleate 




of nucleation and growth. In this study, streak seeding yielded crystals but desolved 
later before collecting diffraction data. Batch seeding resulted in crystals of BSP30b 
with best quality, which had diffraction of ~ 3 Å. Although this is not enough to 
solve the structure of BSP30b using either direct methods or S-SAD, heavy atom 
soaks were performed using those crystals for multiple isomorphous replacement 
(MIR). Gel shift assays had clearly shown binding of gold and platinum atoms to 
BSP30b, however, crystals soaked in their compound solutions failed to generate 
any anomalous signals after scaling the X-ray diffraction dataset. 
4.5.2 Structure of BSP30b Solved Using SeMet Derivative 
The heavy atom selenium has been successfully used for phase determination via 
single-wavelength anomalous dispersion (SAD) after its incorporation into protein 
as the modified residue selenomethionine (SeMet). In this study, we firstly designed 
a double methionine mutant to allow incorporation of SeMet into the protein. 
Although BSP30b_F52M_F106M SeMet derivative was only expressed at low 
levels, it crystallized as rod-cluster shaped crystals with sharp and defined edges 
using the previously determined crystallization conditions. Native BSP30b was 
expressed in pTriEx-4, which leaves a longer 6x His tag at the N-terminal end of 
BSP30b compared to BSP30b_F52M_F106M expressed in pProEx Htb. This 
longer His tag may have increased the flexibility of native BSP30b, which may 
increase the difficulty of producing high quality crystals of native BSP30b. 
Here is the first reported crystal structure of BSP30b at 2.0 Å resolution. The 
structure shows the conserved tubular-like structure of the TULIP superfamily, with 
its hydrophobic channel formed by α/β wrap. Structural comparison to the closely 




unique features which might be important for function. The unique disulfide bond 
present in BSP30b but not in other PLUNC proteins may be important for its ligand 
binding given it proximity to the entrance to the ligand binding cavity. Further 
evidence for this includes the fact that a similar disulfide bond is also found in the 
structure of Takeout 1 of Epiphyas postvittana and JHBP proteins of silkworm, 
which are also members of the TULIP superfamily. Their disulfide bonds are 
reported to have a critical role in ligand binding rather than maintaining the stability 
of the entire structure (Hamiaux et al., 2013; Suzuki et al., 2011). Additional 
evidence is provided by the fact that this disulfide bond is only partially intact in 
the structure of apo-BSP30b and is broken after binding of oleic acid (see Chapter 
5). 
The N-terminal helical part of BSP30b is different from SPLUNC1. For SPLUNC1, 
its N-terminal helices α1 and α2 are V-shaped and the access of potential ligands is 
blocked by helix α1, unless major conformational change occurs to “open-up” the 
binding site. While the re-arrangement of N-terminal helices of BSP30b leaves the 
cavity open.  
 
4.5.3 MBP was Removed During Crystallization of MBP Fused 
BSP30b_F52M_F106M 
It is interesting that crystallization trials using MBP-BSP30b_F52M_F106M 
produced the best-looking crystals (singular and diamond-like, with sharp edges). 
However, those crystals had relative worse diffractions (> 2.4 Å) than 
BSP30b_F52M_F106M. The processed dataset also had worse parameters but still 




The solved structure using MBP-BSP30b_F52M_F106M still maintains the core 
structure of BSP30b. It is interesting that, in both solved structures, the first 38 and 
the last 13 amino acids were missing. This may suggest that those amino acids are 
highly flexible and not well packed in the structure, or they were partially removed 






Chapter Five.  Ligand Binding and Biological 
Function of BSP30b  
5.1 Introduction 
The BSP30b structure maintains the tubular structure of the TULIP superfamily, 
and this suggests that its biological ligand may be a fatty acid similar to those which 
have been proposed to be the ligands of proteins in the TULIP superfamily. Indeed, 
fatty acids were found in the hydrophobic channels of several proteins in the TULIP 
superfamily. Since BSP30b is a salivary protein and the primary lipid source for 
cattle is from pasture grass, the binding of the dominant fatty acids in pasture grass 
to BSP30b was examined by co-crystallization. 
Green Fluorescent Protein (GFP) was discovered as a companion protein to 
aequorin from Aequorea jellyfish. It is widely used in cell biological applications 
as a tag or as an indicator. In this study, BSP30b was fused to GFP so its interaction 
with lipids could be visualized under fluorescent microscope. Olive oil was used 
instead of lipids extracted from pasture grass due to its similar lipid composition 
and availability. 
Because BSP30b secreted in cattle’s saliva will enter the rumen, its interaction with 
rumen microorganisms was also examined. It was thought that BSP30b might bind 
to specific components on certain bacterial surfaces, which may give hints to its 
biological role within the rumen. GFP tagged BSP30b was used and mixed with 





5.2 Purification and Crystallization of 
BSP30b_F52M_F106M with Potential Ligands 
5.2.1 Expression and Purification of BSP30b_F52M_F106M with 
its Potential Ligands 
BSP30b_F52M_F106M was expressed in 1 L LB media instead of M9 minimal 
media for crystallization. However, its expression level was not improved by using 
LB media. The sonicated culture was then purified with IMAC, Anion Exchange 
Chromatography, and SEC. After the final purification step, those fractions 
containing BSP30b were concentrated to 2 mg/mL and incubated with 20 µL of 
either linolenic acid, ethyl linoleate, glycerol monolinoleate, or oleic acid. 
The mixture of BSP30b mutant protein with individual fatty acids was incubated 
overnight and then purified with SEC. Chromatography and SDS PAGE indicated 
that BSP30b mutant showed no change after mixing with fatty acids (Fig. 5.1). It 
eluted as a single peak on chromatography and single band on SDS PAGE. 
 
Figure 5.1 IMAC purification and corresponding SDS-PAGE analysis of BSP30b_F52M_F106M with fatty 





5.2.2 Crystallization of BSP30b Mutant with Potential Ligands 
Co-purified BSP30b mutant with different fatty acids were subjected to fine screens 
at a concentration of 8 mg/ml, separately. After setting up fine screens, most of the 
protein was precipitated in the drop immediately. However, singular crystals with 
sharp edges appeared after about 2 weeks in conditions B3-B6, C3-C6, D3-D6 (Fig. 
5.2). Those crystals were taken to the Australian Synchrotron and most diffracted 
to ~ 2 Å. Data was collected for structure determination in silico. 
 
Figure 5.2 Crystals of BSP30b_F52M_F106M mxied with fatty acids. Singular crystals were appeared after 2 
weeks with sharp edges. It is noted that protein was partially precipitated in the drops as shown in both a and 
b. 
 
5.2.3 Initial Data Analysis 
All the datasets collected for BSP30b mutant with different fatty acids were 
automatically processed and scaled at the Australian Synchrotron. The structures of 
BSP30b mutant with fatty acids were all solved using molecular replacement 
(Phaser-MR in PHENIX suite). The solved structure of BSP30b mutant was used 
as the reference model and all the structures solved by Phaser-MR with high LLG 




Initial inspection of those structures in Coot revealed that only BSP30b mutant co-
crystallized with oleic acid had unoccupied electron densities within its 
hydrophobic channel. Subsequent refinement was carried out for BSP30b mutant-
oleic acid complex only. 
Oleic acid searched from monomer library in Coot was placed into this positive 
contoured electron density and the structure was refined with phenix.refine. 
Subsequent cycles of manual refinement using COOT and automatic refinement 
with phenix.refine were done until Rfree did not reduce further (Table 5.1). 
 
Table 5.1 crystallographic data collection and refinement statistics 
Property Value 
Wavelength 0.95369 Å 
Space group C121 
Cell constants 
a, b, c, α, β, ƴ 
83.75Å     61.40Å     91.09Å 
90.00°      107.74°    90.00°  
Resolution (Å) 86.76 – 1.97 (2.02 – 1.97) 
Rmerge 0.067 (0.683) 
CC (1/2) 0.998 (0.912) 
Completeness (%) 99.7 (99.7) 
Redundancy 5.7 (6.1) 
No. of observations 177824 (13279) 
No. of unique reflections  31005 (2186) 






Total number of atoms 3064 
Average B, all atoms (ligands) (Å2) 55.88 (63.48) 
Ramachandran favoured (outliers) 94.29% (0.54%) 
Rotamer outliers 0.32% 
Clash score 10.36 
 
5.2.4 Structural Analysis of BSP30b Mutant – Oleic Acid Complex 
The protein – oleic acid complex was also solved in C2 space group with two 
protein molecules in its ASU (Fig. 5.3a). The hydrophobic end of oleic acid is 
buried in the tunnel and its carboxyl group stretches out from the tunnel’s opening, 
possibly forming hydrogen bonds with the carboxyl group of ASP112 and the 
carbonyl group of ILE113 (Fig. 5.3b). We suggest that the hydrophobic tail of oleic 
acid first “glides” into the internal cavity, driven by strong hydrophobic 
interactions, while its carboxyl group stretches out and is stabilised by forming 
hydrogen bonds with proximate amino acids. A similar hypothesis has been 
proposed for Epiphyas postvittana Takeout 1 protein (Hamiaux, Basten, 
Greenwood, Baker, & Newcomb, 2013), where both fatty acid ligands (including 
the head groups) “slide down” into the hydrophobic tunnel. 
We also observe that the overall structure of BSP30b and its internal cavity remain 
unchanged regardless of the binding of lipid ligand, suggesting that the internal 
cavity of BSP30b also forms a rigid scaffold for its lipid ligands. Only the helix α3 
moves away very slightly, which may result from the breaking of the unique 




that the internal cavity is narrowed towards its end in the apo structure, while it has 
expanded around the ligand in the ligand bound structure. This is due to the side 
chain movement of L68, L86, F218, and L221, which will optimize the fit around 
the bound ligand.  
 It is also clear that upon ligand binding, the overall B-factor of BSP30b increased 
from 36.0 Å2 to 55.9 Å2, suggesting the ligand bound protein has greater molecular 
motions. For both ligand bound and apo BSP30b, the amino acids forming the 
hydrophobic channel have relatively low B-factors. While the amino acids close to 
the lipid binding opening have much higher B-factors, such as the amino acids of 
helices α3 and α7. 
It is noteworthy that the electron density of oleic acid is relatively clear in one 
molecule of the asymmetric unit but incomplete for oleic acid in the other molecule 
(Fig. 5.3c). The occupancies of both oleic acids in the asymmetric unit were refined 
in PHENIX to 0.81 and 0.86, respectively, suggesting that both of the hydrophobic 
channels are only partially occupied. This may also indicate that oleic acid is not 





Figure 5.3 Structure of BSP30b with bound oleic acid. 3a, the structure of BSP30b with bound oleic acid. Oleic 
acid is coloured in magenta and well-positioned in the internal cavity, which is shown in grey. 3b, surface 
representation of the binding pocket with oleic acid. The potential hydrogen bonds between the carboxyl group 
of oleic acid and carboxyl group of ASP112, and hydroxyl group of ILE113 are shown as yellow dashed lines. 
3c, electron density maps around both oleic acids in the asymmetric unit. The final σa-weighted 2mFo-DFc 
map contoured at 0.8 σ (blue). All structural illustrations were prepared with PyMOL. 
 
5.3 Generation, Expression and Purification of GFP 
(Green Fluorescent Protein) Fused BSP30b 
BSP30b is hypothesised to interact with lipid. To visualize the interaction, N 
terminal GFP tagged BSP30b was created for this purpose. Both genes were cloned 
into pProEx Htb with a N terminal 6x His tag for protein purification.  
5.3.1 Generation of pProEx Htb_sfGFP construct in E. coli BL21 
The sfGFP gene was first amplified from plasmid PIM1773 and ligated into pProEx 




followed by transformation into E. coli BL21. After agarose gel electrophoresis of 
colony PCR amplicons, a band with size of ~720 bp under UV light indicated the 
success of cloning (Fig. 5.4). 
 
Figure 5.4 Colony PCR results. Colony PCR of GFP using gene specific primers, resulting in an ~ 720 bp band 
on agarose gel after electrophoresis. 
 
5.3.2 Generation of pProEx Htb_sfGFP_BSP30b Construct 
The gene encoding BSP30b was ligated into pProEx Htb downstream of the sfGFP 
gene. The BSP30b gene was first amplified from the pTrix4 and ligated into pProEx 
Htb_sfGFP after restriction digestion of both BSP30b amplicon and pProEx Htb 
sfGFP plasmid. The ligated plasmid was transformed into E. coli BL21 cells. 
Colony PCR with gene specific primers gave the PCR amplicon of ~680 bp as 
expected after agarose gel electrophoresis; when using primers targeting both 
sfGFP and BSP30b genes, the PCR amplicon had a size of ~1400 bp on agarose gel 
after electrophoresis (Fig. 5.5). Those results together suggested the success of 






Figure 5.5 Colony PCR results. Colony PCR using gene specific primers for BSP30b resulted a 680 bp band 
on agarose gel after electrophoresis; while colony PCR using primers targeting both sfGFP and BSP30b genes 
resulted a ~ 1400 bp band on agarose gel after electrophoresis. 
 
5.3.3 GFP Tagged BSP30b Expression and Purification 
GFP tagged BSP30b was expressed in LB media as a 55 kDa recombinant protein 
fused to a N terminal 6x histidine tag. The colour change of the media from yellow 
to green after induction immediately indicated the expression of GFP tagged 
BSP30b.  
The expressed protein was first purified with IMAC. The chromatogram and 
corresponding SDS PAGE demonstrate that GFP_BSP30b was well expressed in 
E. coli BL21 and it was successfully eluted off the HisTrap HP column between 
fractions B2 and B8 (Fig. 5.6a). There were some protein impurities which were 
also eluted at the same time, especially those having molecular weights around 
30 kDa. 
The protein was further purified with SEC. The chromatogram and corresponding 




A5 together with few protein impurities, indicated by two close peaks on 
chromatogram and additional bands on SDS-PAGE (Fig. 5.6b). Most of the protein 
impurities were eluted after the desired protein. Proteins from fraction A5 to A10 
were concentrated for future study. 
 
Figure 5.6 Purification of GFP_BSP30b complex. a, chromatogram and corresponding SDS PAGE result of 
IMAC. b, chromatogram and corresponding SDS PAGE result of SEC. Peaks on chromatograms and their 





5.4 Micro emulsions were Formed after Mixing of 
GFP_BSP30b with Olive Oil 
20 μL of olive oil was mixed with 500 μL of GFP_BSP30b at concentration of 2 
mg/ml. After 20 min’s settling of the mixture, two layers were formed. The top 
layer was cloudy and bubbly; the bottom layer was slightly cloudy. When viewed 
under blue light using a fluorescent microscope, the top layer was full of small 
spheres squeezed against each other (Fig. 5.7a). Protein GFP_BSP30b was located 
at the surface of each sphere indicated by the green fluorescence colour under blue 
light. The spheres were made of lipids indicated by the red colour under green light 
(Fig. 5.7b, lipid was stained by Nile Red). The bottom layer also formed spheres 
within the solution, but they were apart from each other. When viewing the 
emulsions under the bench top fluorescent microscope, they also had proteins on 
the surface and lipids inside of micelles (lipid was stained by Nile Red), suggesting 





Figure 5.7 Visualization of emulsions formed by mixing GFP_BSP30b and olive oil under fluorescent 
microscope. When viewed under blue light (a and c), both layer had protein attached to the surface of each 
micelles. Under green light, lipid located inside of each micelles indicated by red colour (b and d, lipid was 
stained by Nile Red). 
 
5.5 Size Distribution of Emulsions 
In order to determine the maximum emulsification ability of BSP30b, the mixture 
of BSP30b and olive oil was vigorously shaked for 10 min followed by settling on 
the bench for 20 min. The size of micelles from the bottom layer was measured 
using the fluorescent microscope at Waikato Biological Imaging Facility. The 
bottom layer was diluted 10 times and the size of each micelle was indicated by 
scale bar on the captured images. It is clear that most of the micelles had a size 
range between sub-micron to a few microns (Fig. 5.8 a and b). However, it is hard 






Figure 5.8 Visualization of micelles under fluorescent microscope at the Waikato Biological Imaging Facility. 
The size of each micelle was indicated by the scale bar on captured images. 
 
To better determine the size of micelles, the emulsion was further visualized using 
TEM at Auckland University. Diluted emulsions were visualized using negative 
stain TEM (Fig. 5.9). The protein coated micelles were negatively stained as white 






Figure 5.9 visualization of micelles under TEM. The size of each micelle was indicated by the scale bar on each 
photo. 
 
5.6 GFP_BSP30b Selectively Binds to Specific Rumen 
Bacteria 
5.6.1 Binding of GFP_BSP30b to Selected Rumen Fluid Micro-
organisms 
The binding ability of GFP_BSP30b to rumen micro-organisms was first examined 
with cheese cloth filtered rumen fluid, which contains all the micro-organisms 




at 0.1 mg/ml was tested to be the optimal concentration for viewing under 
fluorescent microscope when mixed with rumen fluid at a ratio of 1:1.  
When viewing the mixture under bright field, both protozoa and bacteria were 
clearly seen together with dry matter residues (Fig. 5.10a). After switching to blue 
light, only bacteria were fluorescent but it is hard to determine their morphologies 
and whether all bacteria were bound by GFP_BSP30b (Fig. 5.10b). To further 
investigate the binding specificity of GFP_BSP30b, protozoa and bacteria were 
separated and their binding to GFP_BSP30b was investigated respectively. 
 
Figure 5.10 Binding assay of GFP_BSP30b to rumen fluid. a, photo was taken under bright field. Protozoa, 
bacteria, and drymatter residues were seen. b, photo was taken under blue light. Only bacteria was fluorescent 





5.6.2 GFP_BSP30b does not Bind to Protozoa from Rumen 
When viewing the protozoal fraction mixture with GFP_BSP30b under bright field, 
protozoa were clearly seen as in figure 5.11a. Whilst viewing the mixture under 
blue light, there were no fluorescent signals for protozoa, suggesting that there is 
no interaction between protozoa and BSP30b. It was noticed that there was one 
glowing spot on the left of figure 5.11b, which could be bacterial contamination in 
the protozoal fraction. 
 
Figure 5.11 Binding assay of GFP_BSP30b to protozoa fraction of rumen fluid. a, photo was captured under 
bright field. Protozoa was seen in this fraction. b, photo was taken under blue light. Only the outline shade of 
protozoa was seen, suggesting no binding of protein to protozoa. The single bright spot could be bacteria 





5.6.3 GFP_BSP30b Selectively Binds to Certain Rumen Bacteria 
When viewing the mixture of bacteria and protein under bright field, a range of 
bacterial species were seen (Fig. 5.12a). The most surprising result to us is the 
observation that the mixture of GFP_BSP30b with ruminal bacteria observed under 
blue light shows that BSP30b binds to just a small number of rumen bacterial 
species (Fig. 5.12b). It is clearly seen that BSP30b has specific binding to a short 
and curved rod-like bacterial species, which is clustered as a triad or tetrad (Fig. 
5.12b). We observed that BSP30b can also bind to a few cocci-like species but the 
binding is relatively weak. We suggest that the binding specificity of BSP30b to 
certain bacterial surface lipids may result in its binding selectivity to a small subset 





Figure 5.12 Binding assay of GFP_BSP30b to bacterial fraction of rumen fluid. a, under bright field, rumen 
bacteria with different morphologies were seen. b, under blue light, only a small fraction of rumen bacteria 
was fluorescent.  
 
5.7 Discussion 
5.7.1 BSP30b is A Lipid Binding Protein 
Although PLUNC proteins belong to the TULIP lipid binding protein superfamily, 
there was no structure of PLUNC proteins that has been solved with its lipid ligands. 
Although SPLUNC1 from human has been demonstrated to bind to DPPC using 
lipid binding assay on solid surface, its structure did not show any lipid binding to 
its internal cavity. 
This is the first time that a PLUNC family protein has been crystallized with a 
ligand (oleic acid), although the electron density map of the ligand is not complete. 
We have also tried to crystalize BSP30b with linolenic acid and linoleic acid, but 
in the structural data showed no electron density for either fatty acids. Linolenic 
acid and linoleic acid have more rigid structures compared to oleic acid as they have 
three and two double bonds on their carbon backbones, respectively. In contrast, 
oleic acid has only one double bond, which gives it more flexibility and make the 
“sliding” of oleic acid into the relatively narrow hydrophobic channel possible.  
It was noticed that there is no major conformational change of BSP30b after oleic 
acid binding. Its overall structure and hydrophobic channel were well maintained. 
This is in contrast to the lipid binding hypothesis for SPLUNC1. It was 
hypothesized that upon lipid ligand binding, a major conformational change was 
needed to open-up the hydrophobic channel of SPLUNC1. Since SPLUNC1 has the 




a similar lipid binding mechanism. Possibly, upon lipid binding of SPLUNC1, its 
helix α4 will move aside but no major conformational change will be needed. After 
helix α4 moves away, its hydrophobic channel will be exposed to its lipid ligands 
and ready to accommodate them. This also could be the case for latherin, a PLUNC 
protein from horse sweat and saliva. It has similar structure to SPLUNC1 and its C-
terminal helix could move away upon lipid binding. 
We believe this rigid structure of BSP30b constrains its lipid ligand profile. 
Although BSP30b was crystallized with oleic acid, it is not the preferred lipid ligand 
indicated by its poor electron density profile. We have shown that fatty acids with 
two or three double bonds on their carbon back bones weren’t co-crystallized with 
BSP30b. This is presumably because they have more rigid structures compared with 
those lipids with no or just one double bond on their carbon back bones. All of these 
may suggest that the lipid ligands of BSP30b should have no more than one carbon-
carbon double bond.  
Moreover, its hydrophobic channel can only accommodate one carbon chain. This 
is similar to JHBP and Takeout proteins, whose substrate has only one carbon chain 
(Hamiaux et al., 2013; Suzuki et al., 2011). In contrast, the substrates of BPI or 
CETP have two carbon chains and both of these are accommodated in their 
hydrophobic channel (Kleiger et al., 2000; Qiu et al., 2007). This may suggest that 






5.7.2 Function Studies Using GFP Fused BSP30b 
Green Fluorescent protein (GFP) was discovered in Aequorea jellyfish, which is a 
companion protein to the famous chemiluminescent protein – aequorin 
(Shimomura, Johnson, & Saiga, 1962). For cell biological application, GFP was 
first used to detect gene expression in vivo. In the nematode Caenorhabditis elegans, 
GFP successfully confirmed the expression pattern of the mec-7 promotor, which 
drives the formation of β-tubulin in a limited number of mechanosensory neurons 
(Chalfie, Tu, Euskirchen, Ward, & Prasher, 1994). GFP is also particularly 
promising in intact transgenic embryos and animals as well as for monitoring the 
effectiveness of gene transfer because of its independence from enzymatic 
substrates (Ikawa et al., 1995; Levy, Muldoon, Zolotukhin, & Link, 1996). 
Nevertheless, GFP needs strong promoters to drive sufficient expression for 
detection, especially in mammalian cells (Tsien, 1998).  
The most successful application of GFP has been as a genetic fusion partner to host 
proteins, which helps to monitor their location and fate (Tsien, 1998). The fused 
protein will be expressed in the cell or organism of interest, which ideally maintains 
the normal functions and localizations of the host protein but is now fluorescent. 
Practically, all of the major organelles of the cell have been targeted by GFP, 
including plasma membrane, nucleus, endoplasmic reticulum, Golgi apparatus and 
et. al (Tsien, 1998). 
In this study, BSP30b was fused to GFP to visualise its possible functions. Instead 
of monitoring the location of GFP fused protein in vivo, we investigated the location 




5.7.3 BSP30b is A Bio-emulsifier 
Emulsion is a fine dispersion of a droplet phase stabilized by a thin film, usually a 
monomolecular film of an emulsifier. There are basically two different types of 
emulsions: oil in water (o/w emulsion) or water in oil (w/o emulsion). The emulsion 
system is thermodynamically unstable, which tends to separate into an oil and an 
aqueous phase with time (Nursakinah, Ismail, Rahimi, & Idris, 2013). 
Many proteins are surface active molecules, which form monolayers on aqueous 
solutions or the interlayer between oil and water (McClements, 2004). They also 
have the property of forming clusters and micelles in the bulk. Those proteins can 
be used as emulsifiers based on their ability to facilitate this formation, improve the 
stability and produce desirable physicochemical properties in oil-in-water 
emulsions. Proteins will adsorb to the surface of oil droplets created by 
homogenization of oil-water-protein mixtures, where proteins will facilitate further 
droplet disruption by lowering the interfacial tension and prevent droplet 
coalescence by forming a protective membrane around the droplets (McClements, 
2004). 
Proteins in the PLUNC family are proven to have potent surfactant properties at 
water/liquid interface (J. A. Bartlett et al., 2011; McDonald et al., 2009). Latherin 
from the sweat and saliva of horses is believed to be a highly surface-active allergen 
protein. It probably functions as a wetting agent in evaporative cooling in horses 
and may also assist in mastication of fibrous food as well as inhibition of microbial 
biofilms. The surfactant activity of SPLUNC1 from human has also been 
investigated by using a variety of in vitro assays. Contact angle studies showed that 




to drops containing buffer alone or control proteins. It was also found that 
recombinant SPLUNC1 reduced surface tension in a dose-dependent manner by 
using a pulsating bubble surfactometer. 
Here, we demonstrated that BSP30b behaves like an emulsifier, dispersing olive oil 
into small droplets in aqueous solution. We also suggest that its emulsification 
ability comes from its binding to the fatty acid chains of glycerides, with small 
spheres forming in the solution. The internal core of each sphere is full of lipids 
while the surface is coated by BSP30b, the polar side chains of whose amino acids 
are exposed to the solution, keeping the micelles soluble. 
 
5.7.4 BSP30b Selectively Binds to Certain Rumen Bacterial 
Species 
The most interesting finding in this study is that BSP30b only binds to a small 
portion of bacteria species within rumen. “Bacteria coating” by proteins from the 
PLUNC group has been reported before (Robinson et al., 1997; Sayeed, Nistico, St 
Croix, & Di, 2013b). The binding of murine PSP to E. coli, S. mutans, A. 
actinomycetemcomitans, and L. monocytogenes has been demonstrated to be 
protein-protein interactions dependent on the presence of Zn2+. However, we 
suggest that BSP30b binds to the lipids on the bacterial surface. The “bacterial cell 
coating” by human SPLUNC1 of P. aeruginosa-pMF230 has been investigated 
using confocal microscopy, and the protein is proposed to display a bacteriostatic 
property in preventing bacterial growth. But other studies also report that this anti-




et al., 2010b). Here, we propose that BSP30b could have important roles in the 






Chapter Six. Conclusion 
6.1 General Background 
BSP30b from cattle is an acidic protein (pI = 4.4) with a molecular weight of 
~30 kDa, which is proposed to have arisen through a series of gene duplications 
(Haigh et al., 2008). BSP30b was first identified from SDS PAGE analysis of 
bovine salivary proteins. Its abundance in saliva was related to the bloat 
susceptibility of cattle. Although BSP30b was suggested to be a BPI-like protein, it 
failed to bind LPS and only had moderate antimicrobial activity against two 
P. aeruginosa strains (Haigh et al., 2008).  
Despite the high expression of BSP30b in the saliva of cattle, its function is still 
unclear. One difficulty is that the functions of most PLUNC proteins are largely 
unknown. Although PLUNC proteins from human have been intensively 
investigated, especially hSPLUNC1, their functions are still inconclusive (Ning et 
al., 2014; Sayeed et al., 2013a; Zhou et al., 2008). Another difficulty is that until 
now, the structures of only two PLUNC proteins have been solved and both without 
ligands. All of these difficulties impede our understanding of the biological 
functions of PLUNC proteins. 
This project was undertaken to investigate the structural characteristics and 





6.2 BSP30b is a TULIP protein 
Although BSP30b has been demonstrated to be a TULIP protein from sequence 
analysis, our structural result further confirms this. Each molecule of BSP30b 
adopts a slightly curved cylindrical structure with a hydrophobic channel formed 
by an α/β wrap, which is highly conserved in the TULIP superfamily. Moreover, 
BSP30b also has the conserved disulfide bond seen across the PLUNC family, 
which connects the α helix and β sheet region and stabilizes the whole structure.  
Compared to other TULIP superfamily proteins, BSP30b also has its own unique 
features. Firstly, its N terminal consists of four helices (α1-α4) while there are only 
two helices (α1 and α2) present in SPLUNC1/Latherin. The respective N-terminus 
and C-terminus of BSP30b are located on the opposite ends but they are on the same 
side for SPLUNC1/Latherin. .Moreover, its internal cavity opening is covered by a 
flexible loop. Compared to the solved structures of hSPLUNC1 and Latherin, 
BSP30b has an enlarged internal cavity. These features enable the binding of ligand 
without any major conformational changes. However, there are still some local 
adjustments of side chains around the bound ligand. An extra disulfide bond has 
also been observed in the structure of BSP30b. The electron density is clear in one 
molecule of its ASU but is missing in another molecule. Although the electron 
densities are completely missing in the ligand bound structure, it is still not 
conclusive regarding the role of the second disulphide bond. 
We co-crystallised BSP30b with oleic acid bound in its hydrophobic channel. This 
is the first time that a ligand has been seen in the structure of a PLUNC group 
protein. Despite oleic acid not being the ideal ligand for BSP30b (as previously 




acid, having a long hydrophobic carbon chain with reasonable flexibility. Since all 
the TULIP proteins have been proposed to be lipid binding proteins, the ligand of 
BSP30b should have these properties. 
6.3 BSP30b is a Surfactant Protein 
In this study, BSP30b has been shown to have surfactant properties. This is 
consistent with the studies on SPLUNC1 and latherin. The surfactant activity of 
SPLUNC1 from human has been investigated by using a variety of in vitro assays. 
Latherin from horse saliva and sweat has been proposed to be first localized to the 
non-polar interface via its flexible loops at one end of the protein molecule, which 
then unfolds and flattens to expose its hydrophobic interior to the air or non-polar 
surface. 
However, our finding suggests that BSP30b fulfils its surfactant property without 
unfolding or flattening to expose its hydrophobic interior. From our emulsification 
study, we propose that the fatty acid moiety of triglyceride will enter the 
hydrophobic pocket forming a protein layer around the lipid droplet. These results 
could give us some indication as to the functions of BSP30b pertaining to lipolysis 
or biohydrogenation within rumen. Its interaction with lipids could facilitate the 
lipolysis or biohydrogenation. 
6.4 The interaction between BSP30b and rumen bacteria 
The rumen is a complex ecosystem, in which nutrients consumed by ruminant are 
fermented by microorganisms living in the rumen. The diet influence on rumen 
fermentation has been well studied. However, the contribution of ruminant salivary 




Here, we investigated the potential roles of salivary protein BSP30b within rumen. 
We used a GFP tag to indicate the location of BSP30b within the rumen samples. 
Our results showed that BSP30b specifically binds to certain rumen bacterial 
species. This is the first time to look at the interaction between ruminant salivary 
protein and rumen bacteria.  It would be interesting to determine which rumen 
bacteria species are targeted by BSP30b using FACS (fluorescence-activated cell 
sorting) and 16S RNA gene sequencing from these bacteria. Furthermore, this 
binding may have crucial effects on rumen microbial metabolism. This hypothesis 
can be addressed by culturing the microbe in isolation (if possible) and using 
RNAseq methods to analyse genes that are up- or down- regulated in response to 
BSP30b protein bidning. It will be also interesting to use metabolomics at the level 
of rumen contents with and without BSP30b protein to identify community 
metabolic differences in the rumen. This could provide us with insights into the 
biological role(s) of the BSP30 proteins in the rumen at the scale of individual 
bacteria and at the community scale. 
 
6.5 Future Research 
Research presented in this thesis provides the structure of BSP30b and its ligand 
binding. It would be of great interest to further determine the ligand of BSP30b by 
exploring BSP30b bound bacterial surface lipids. This could include using methods 
such as co-crystallization of the protein and the ligand under investigation for 
binding. This can further our understanding on the binding mechanism of BSP30b 




In this study, we have described the morphologies of the rumen bacteria bound to 
BSP30b, further characterization of the bound bacteria can be undertaken by using 
FACS (fluorescence-activated cell sorting) and NGS (next generation sequencing). 
The bacteria bound by GFP_BSP30b can be separated from un-bound bacteria by 
FACS, which can purify the GFP_BSP30b bound bacteria based upon GFP 
fluorescence. The genus of these enriched bacteria can be then determined by NGS 
targeting the 16s rRNA gene region. Once the bacteria species are identified, the 
potential regulatory roles of BSP30b on the associated metabolic and fermentation 
pathways can be analysed using a combination of specialised culture methods, 
metabolomics and RNA sequencing. 
It may be the case that the main role for BSP30b is to simply inhibit growth of 
particular species within rumen. However, it is much more likely that BSP30b is 
regulating metabolism in some way. To prove this, metabolomics approaches can 
be undertaken on microbial cultures (with and without BSP30b protein). 
Overall, undertanding more fully the binding characteristics of BSP30b will have 
broader implications for understanding nutrient availability and rumen metabolism 
within ruminants. The predicted regulation roles of BSP30b can potentially offer 
improvements in productivity in the dairy and beef industries through identifying 






A1: Buffers and solutions 
Electrophoresis buffers were made with distilled water whereas chromatography 
buffers were made with MQ water and were then filtered with a 0.2 μm filter prior 
to use. Loading dye was made using MQ water. 
10 x DNA loading dye 0.4% (w/v) bromophenol blue, 0.4% (w/v) xylene 
cyanol, 50% (v/v) glycerol 
Fairbanks A stain 0.05% (w/v) coomassie blue R-250, 25% (v/v) 
isopropanol, 10% (v/v) acetic acid 
Fairbanks B stain 0.005% (w/v) coomassie blue R-250, 10% (v/v) 
isopropanol, 10% (v/v) acetic acid 
Fairbanks C stain 0.002% (w/v) coomassie blue, 10% (v/v) acetic acid 
Fairbanks D stain 10% (v/v) acetic acid 
5 x native loading dye 300 mM Tris-HCl pH 6.8, 50% (v/v) glycerol and 
0.05% (w/v) bromophenol blue 
4 x SDS loading dye 200 mM Tris-HCl pH 6.8, 8% (w/v) SDS, 40% (v/v) 
glycerol, 0.4% (w/v) bromophenol blue, 400 mM β-
mercaptoethanol 
50 x TAE  242 g Tris base, 57.1 ml glacial acetic acid, 100 ml 




10 x TAE 400 mM Tris-acetate, 10 mM EDTA 
1 x TAE  100 ml 10 x TAE + 900 ml H2O 
TE 10 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0 
 
A2: Growth media 
Dehydrated Difco™, BDL™ and Bacto™ media and ADC enrichment media was 
supplied by Becton, Dickinson and Company, USA. Growth media was made up in 
distilled water and sterilised by autoclaving at 121°C for 15 minutes. 
LB 1% (w/v) bactotryptone or bactopeptone, 0.5% (w/v) yeast 
extract, 1% (w/v) NaCl, pH 8.0, autoclave 
LB agar  1% (w/v) bactotryptone or bactopeptone, 0.5% (w/v) yeast 
extract, 1% (w/v) NaCl, 15 g/L agar, pH 8.0, autoclave 
M9 salts  42 mM Na2HPO4, 22 mM KH2PO4, 19 mM NH4Cl, 8.5 
mM NaCl, pH to 7.4 with 10 M NaOH, autoclave 
M9 minimal  42 mM Na2HPO4, 22 mM KH2PO4, 19 mM NH4Cl, 8.5 
mM NaCl, pH to 7.4 with 10 M NaOH, autoclave, then add 
sterile 2 mM MgSO4, 0.1 mM CaCl2 and 0.4% (w/v) 
glucose 
PA-0.5G  50 mM Na2HPO4, 50 mM KH2PO4, 25 mM (NH4)2SO4, 
1 mM MgSO4, 0.5% (w/v) glucose, 0.1 x metals mix***, 




methionine auxotroph DL41 add 100 μg/ml methionine. 
Individual components autoclaved or sterile filtered before 
adding to sterile dH2O 
PASM-5052  50 mM Na2HPO4, 50 mM KH2PO4, 25 mM (NH4)2SO4, 
1 mM MgSO4, 0.5% (w/v) glycerol, 0.05% (w/v) glucose, 
0.2% (w/v) α-lactose, 1 x metals mix***, 100 nM vitamin 
B12, 200 μg/ml each of 17 amino acids (no Cys, Tyr or Met), 
10 μg/ml methionine, 125 μg/ml selenomethionine 
Rich media + glucose  1% (w/v) bactotryptone, 0.5% (w/v) yeast extract, 0.5% 
(w/v) NaCl, 0.2% (w/v) glucose 
SOC  2% (w/v) bactotryptone or bactopeptone, 0.5% (w/v) yeast 
extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgSO4, 10 
mM MgCl2, autoclave. Once cooled add sterile glucose to 
20 mM 
*100 x trace metals stock for HdB media: EDTA [0.1 g], MgCl2.6H2O [1 g], 
CaCl2.2H2O [10 mg], NaMoO4.2H2O [2 mg], CoCl2.6H2O [4 mg], MnCl2.2H2O 
[10 mg], ZnSO4.7H2O [20 mg], FeSO4.7H2O [50 mg], CuSO4.5H2O to 100 ml 
with dH2O. 
**100 x phosphate stock for HdB media: K2HPO4 [15.5g], NaH2PO4.2H2O 
[11.1g] to 100 ml with dH2O. 
***1000 x metals mix made up from the sterile stock solutions of each component 




μM CaCl2, 10 μM MnCl2, 10 μM ZnSO4, 2 μM CoCl2, 2 μM CuCl2, 2 μM NiCl2, 
2 μM Na2MoO4, 2 μM Na2SeO3, 2 μM H3BO3. 
 
A3: Primers used in this study 
 
Table A.1 Primers used in this study 
primer Sequence Tm 
BSP30b_DM_F1 CTGGTTCTGCTGTGTGGTCT 64.4 °C 
pProEx_Rev_BSP30 ACTTCTGAGTTCGGCATGGG 64.5 °C 
F GGATCCAGCCTGCCGGATAT 62.5 °C 







GFP_forward GGATCCGGCTCCAAAGGCGAGGAA 68.6 




















































A5: Robotic Screen Conditions with Crystal “Hits” for 
BSP30b 







IndexTM – HR2-144 
82. 
0.2 M Magnesium chloride hexahydrate 
0.1 M BIS-TRIS pH 5.5 
25% w/v Polyethylene glycol 3,350 
84. 
0.2 M Magnesium chloride hexahydrate 
0.1 M HEPES pH 7.5 
25% w/v Polyethylene glycol 3,350 
85. 
0.2 M Magnesium chloride hexahydrate 
0.1 Tris pH 8.5 
25% w/v Polyethylene glycol 3,350 
 
PEGRx HTTM – HR2-086 
41. 
0.1 M Sodium citrate tribasic dehydrate pH 
5.5 







Crystal Screen HTTM – 
HR2-130 
14. 
0.2 M Calcium chloride dehydrate 
0.1 M HEPES pH 7.5 
30% v/v Polyethylene glycol 400 
23. 
0.2 M Magnesium chloride hexahydrate 
0.1 M HEPES pH 7.5 
30% v/v Polyethylene glycol 400 
82. 
0.05 M Cadmium sulfate hydrate 
0.1 M HEPES pH 7.5 








A6: Bacterial strains used in this study 
 
Table A.2 Bacterial strains used in this study 
Strain Description 
DH5α High efficiency transformation and high plasmid copy number. 
Inactivated intracellular endonucleases for high plasmid DNA 
yield. 
BL21 (DE3) DE3 lysogen contains T7 polymerase upon IPTG induction. 
This strain is deficient of lon and omp-t proteases and is 
therefore suitable for expression of non-toxic genes. 
 
A7: Plasmids used in this study 
Table A.4 Plasmids used in this study 
Plasmid Description 
pPROExHTb E. coli expression vector. Trc promoter. Encodes an 
N-terminal 6 x histidine tag with an rTEV protease 
cleavage site. Ampicillin resistance (Invitrogn, 
USA). 
pMAL-c2x E. coli expression vector. Tac promoter. Encodes 
malE for expression of an N-terminal MBP fusion 
tag with a Factor Xa protease cleavage site. 
Ampicillin resistance (NEB, USA). 
pMA-T E. coli expression vector. Carrier of synthetic 
genes. Ampicillin resistance (GeneArt Life 
Technologies, USA) 
pTriEx-4 Uniquely designed to allow rapid characterization 




Expression in E. coli is regulated by T7 promoter. 
Ampicillin resistance (EMD Millipore, USA) 
 
A8: Plasmid constructs used in this study. 
Table A5 Plasmid constructs used in this study 
Plasmid Description Reference 
BSP30b-pTriEx-4 pTriEx-4 with BSP30b inserted 
into LIC site. 




pMA-T with synthesized 
BSP30b_F52M_F106M inserted 





pProEx Htb with 
BSP30b_F52M_F106M inserted 







into BamHI/PstI restriction sites. 
This study 
GFP-BSP30b-pProEx Htb pProEx Htb with GFP and 
BSP30b inserted. GFP was 
cloned into BamHI/PstI 
restriction sites. While BSP30b 
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